US20080241916A1 - Multiple Gene Expression For Engineering Novel Pathways And Hyperexpression Of Foreign Proteins in Plants - Google Patents
Multiple Gene Expression For Engineering Novel Pathways And Hyperexpression Of Foreign Proteins in Plants Download PDFInfo
- Publication number
- US20080241916A1 US20080241916A1 US11/938,331 US93833107A US2008241916A1 US 20080241916 A1 US20080241916 A1 US 20080241916A1 US 93833107 A US93833107 A US 93833107A US 2008241916 A1 US2008241916 A1 US 2008241916A1
- Authority
- US
- United States
- Prior art keywords
- vector
- protein
- mercury
- plant
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 title claims description 255
- 102000004169 proteins and genes Human genes 0.000 title claims description 112
- 230000014509 gene expression Effects 0.000 title claims description 77
- 230000037361 pathway Effects 0.000 title claims description 23
- 210000003763 chloroplast Anatomy 0.000 claims abstract description 133
- 239000013598 vector Substances 0.000 claims abstract description 99
- 230000009466 transformation Effects 0.000 claims abstract description 31
- 230000001131 transforming effect Effects 0.000 claims abstract description 16
- 241000196324 Embryophyta Species 0.000 claims description 231
- 230000009261 transgenic effect Effects 0.000 claims description 85
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 77
- 229910052753 mercury Inorganic materials 0.000 claims description 63
- 210000004027 cell Anatomy 0.000 claims description 57
- 210000002706 plastid Anatomy 0.000 claims description 54
- 230000000749 insecticidal effect Effects 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 36
- 239000013078 crystal Substances 0.000 claims description 30
- 108050001186 Chaperonin Cpn60 Proteins 0.000 claims description 28
- 102000052603 Chaperonins Human genes 0.000 claims description 28
- 230000010354 integration Effects 0.000 claims description 27
- 241000238631 Hexapoda Species 0.000 claims description 24
- -1 alkyl mercury Chemical compound 0.000 claims description 23
- 229910052751 metal Inorganic materials 0.000 claims description 23
- 239000002184 metal Substances 0.000 claims description 23
- 230000000243 photosynthetic effect Effects 0.000 claims description 21
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 20
- 229940088598 enzyme Drugs 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000002689 soil Substances 0.000 claims description 16
- 150000001413 amino acids Chemical class 0.000 claims description 15
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 claims description 15
- 229960000268 spectinomycin Drugs 0.000 claims description 15
- 108700012359 toxins Proteins 0.000 claims description 15
- 108091026890 Coding region Proteins 0.000 claims description 14
- 150000001768 cations Chemical class 0.000 claims description 14
- 235000001014 amino acid Nutrition 0.000 claims description 13
- 230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 13
- 241000192584 Synechocystis Species 0.000 claims description 12
- 239000003550 marker Substances 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 230000006870 function Effects 0.000 claims description 11
- 230000012010 growth Effects 0.000 claims description 11
- 229910021645 metal ion Inorganic materials 0.000 claims description 11
- 125000006850 spacer group Chemical group 0.000 claims description 11
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 10
- 229940097012 bacillus thuringiensis Drugs 0.000 claims description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 10
- 240000009108 Chlorella vulgaris Species 0.000 claims description 9
- 235000007089 Chlorella vulgaris Nutrition 0.000 claims description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 9
- 238000009825 accumulation Methods 0.000 claims description 9
- 229960000074 biopharmaceutical Drugs 0.000 claims description 9
- 229910052737 gold Inorganic materials 0.000 claims description 9
- 239000010931 gold Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000013604 expression vector Substances 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 7
- 239000003053 toxin Substances 0.000 claims description 7
- 231100000765 toxin Toxicity 0.000 claims description 7
- 230000006801 homologous recombination Effects 0.000 claims description 6
- 238000002744 homologous recombination Methods 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 229910052709 silver Inorganic materials 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- 230000005030 transcription termination Effects 0.000 claims description 6
- 241000195628 Chlorophyta Species 0.000 claims description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 5
- 244000061456 Solanum tuberosum Species 0.000 claims description 5
- 229910017052 cobalt Inorganic materials 0.000 claims description 5
- 239000010941 cobalt Substances 0.000 claims description 5
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 5
- 229910052759 nickel Inorganic materials 0.000 claims description 5
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 241000192700 Cyanobacteria Species 0.000 claims description 4
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 4
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 4
- 101150075980 psbA gene Proteins 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 235000010726 Vigna sinensis Nutrition 0.000 claims description 3
- 244000042314 Vigna unguiculata Species 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 229940093920 gynecological arsenic compound Drugs 0.000 claims description 3
- 150000002731 mercury compounds Chemical class 0.000 claims description 3
- 150000002739 metals Chemical class 0.000 claims description 3
- 230000008635 plant growth Effects 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 108090001061 Insulin Proteins 0.000 claims description 2
- 102000004877 Insulin Human genes 0.000 claims description 2
- 101150008263 accD gene Proteins 0.000 claims description 2
- 239000003392 amylase inhibitor Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000003673 groundwater Substances 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 229940125396 insulin Drugs 0.000 claims description 2
- 150000002736 metal compounds Chemical class 0.000 claims description 2
- 238000013519 translation Methods 0.000 claims description 2
- 239000002753 trypsin inhibitor Substances 0.000 claims description 2
- 101710151559 Crystal protein Proteins 0.000 claims 6
- 238000012258 culturing Methods 0.000 claims 3
- 230000001172 regenerating effect Effects 0.000 claims 3
- 108010089254 Cholesterol oxidase Proteins 0.000 claims 2
- 229940065285 cadmium compound Drugs 0.000 claims 2
- 150000002484 inorganic compounds Chemical class 0.000 claims 2
- 229910010272 inorganic material Inorganic materials 0.000 claims 2
- 150000002894 organic compounds Chemical class 0.000 claims 2
- 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 claims 1
- 230000000361 pesticidal effect Effects 0.000 claims 1
- 210000001916 photosynthetic cell Anatomy 0.000 claims 1
- 108700026220 vif Genes Proteins 0.000 claims 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 abstract description 33
- 244000061176 Nicotiana tabacum Species 0.000 abstract description 32
- 241000208125 Nicotiana Species 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 92
- 239000000047 product Substances 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 23
- 239000012634 fragment Substances 0.000 description 19
- 101150054612 merA gene Proteins 0.000 description 18
- 101150109460 merB gene Proteins 0.000 description 18
- 101100237157 Bacillus cereus merB1 gene Proteins 0.000 description 17
- 238000004166 bioassay Methods 0.000 description 16
- JJWSNOOGIUMOEE-UHFFFAOYSA-N Monomethylmercury Chemical compound [Hg]C JJWSNOOGIUMOEE-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 239000008188 pellet Substances 0.000 description 14
- 239000002609 medium Substances 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 10
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 241000255967 Helicoverpa zea Species 0.000 description 9
- 108700026244 Open Reading Frames Proteins 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000002965 ELISA Methods 0.000 description 8
- 101150067314 aadA gene Proteins 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 101100065514 Mus musculus Eral1 gene Proteins 0.000 description 7
- 108090000854 Oxidoreductases Proteins 0.000 description 7
- 102000004316 Oxidoreductases Human genes 0.000 description 7
- 240000000111 Saccharum officinarum Species 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000010353 genetic engineering Methods 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
- 231100000419 toxicity Toxicity 0.000 description 7
- 230000001988 toxicity Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 241000209499 Lemna Species 0.000 description 6
- 108010006519 Molecular Chaperones Proteins 0.000 description 6
- 235000007201 Saccharum officinarum Nutrition 0.000 description 6
- 238000002105 Southern blotting Methods 0.000 description 6
- 241000256247 Spodoptera exigua Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- BQPIGGFYSBELGY-UHFFFAOYSA-N mercury(2+) Chemical compound [Hg+2] BQPIGGFYSBELGY-UHFFFAOYSA-N 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 108020005345 3' Untranslated Regions Proteins 0.000 description 5
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 5
- 241000256244 Heliothis virescens Species 0.000 description 5
- 102000005431 Molecular Chaperones Human genes 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 210000003000 inclusion body Anatomy 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- JCIIKRHCWVHVFF-UHFFFAOYSA-N 1,2,4-thiadiazol-5-amine;hydrochloride Chemical compound Cl.NC1=NC=NS1 JCIIKRHCWVHVFF-UHFFFAOYSA-N 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 241000219146 Gossypium Species 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 4
- 108020005120 Plant DNA Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108020004566 Transfer RNA Proteins 0.000 description 4
- KRWTWSSMURUMDE-UHFFFAOYSA-N [1-(2-methoxynaphthalen-1-yl)naphthalen-2-yl]-diphenylphosphane Chemical compound COC1=CC=C2C=CC=CC2=C1C(C1=CC=CC=C1C=C1)=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 KRWTWSSMURUMDE-UHFFFAOYSA-N 0.000 description 4
- 108010042363 alkylmercury lyase Proteins 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 229910052793 cadmium Inorganic materials 0.000 description 4
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000030279 gene silencing Effects 0.000 description 4
- 238000012226 gene silencing method Methods 0.000 description 4
- 230000035784 germination Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229940096826 phenylmercuric acetate Drugs 0.000 description 4
- 238000012021 retail method of payment Methods 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 230000002103 transcriptional effect Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 108020004998 Chloroplast DNA Proteins 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 108091029865 Exogenous DNA Proteins 0.000 description 3
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000000635 electron micrograph Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000013505 freshwater Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000007523 nucleic acids Chemical group 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000002731 protein assay Methods 0.000 description 3
- 230000012846 protein folding Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 239000002676 xenobiotic agent Substances 0.000 description 3
- 108020003589 5' Untranslated Regions Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 101100439426 Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) groEL4 gene Proteins 0.000 description 2
- 101000583086 Bunodosoma granuliferum Delta-actitoxin-Bgr2b Proteins 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000030527 Minamata disease Diseases 0.000 description 2
- 208000009507 Nervous System Mercury Poisoning Diseases 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 238000010222 PCR analysis Methods 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 108010081996 Photosystem I Protein Complex Proteins 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008236 biological pathway Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 101150077981 groEL gene Proteins 0.000 description 2
- 101150006844 groES gene Proteins 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 238000003126 immunogold labeling Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 229960002523 mercuric chloride Drugs 0.000 description 2
- 238000012269 metabolic engineering Methods 0.000 description 2
- 229940008718 metallic mercury Drugs 0.000 description 2
- 230000000696 methanogenic effect Effects 0.000 description 2
- 238000005065 mining Methods 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- YFZOUMNUDGGHIW-UHFFFAOYSA-M p-chloromercuribenzoic acid Chemical compound OC(=O)C1=CC=C([Hg]Cl)C=C1 YFZOUMNUDGGHIW-UHFFFAOYSA-M 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 238000005067 remediation Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012723 sample buffer Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000002377 thylakoid Anatomy 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- NBCQBGBECVUZMK-UHFFFAOYSA-N (4-carboxyphenyl)mercury;hydrate Chemical compound O.OC(=O)C1=CC=C([Hg])C=C1 NBCQBGBECVUZMK-UHFFFAOYSA-N 0.000 description 1
- 102100024341 10 kDa heat shock protein, mitochondrial Human genes 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 101100301006 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) cbbL2 gene Proteins 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 108700003860 Bacterial Genes Proteins 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241001513358 Billardiera scandens Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 108010059013 Chaperonin 10 Proteins 0.000 description 1
- 108010058432 Chaperonin 60 Proteins 0.000 description 1
- 108700031407 Chloroplast Genes Proteins 0.000 description 1
- 108010049994 Chloroplast Proteins Proteins 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241001464430 Cyanobacterium Species 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000605739 Desulfovibrio desulfuricans Species 0.000 description 1
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
- 240000006497 Dianthus caryophyllus Species 0.000 description 1
- 244000207543 Euphorbia heterophylla Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000009438 Gossypium Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 108091027974 Mature messenger RNA Proteins 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000204900 Talipariti tiliaceum Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000589499 Thermus thermophilus Species 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 108010006886 Vitrogen Proteins 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 150000001495 arsenic compounds Chemical class 0.000 description 1
- 235000021405 artificial diet Nutrition 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 239000012911 assay medium Substances 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000853 biopesticidal effect Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 101150004101 cbbL gene Proteins 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ATZBPOVXVPIOMR-UHFFFAOYSA-N dimethylmercury Chemical compound C[Hg]C ATZBPOVXVPIOMR-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000000469 dry deposition Methods 0.000 description 1
- 238000010218 electron microscopic analysis Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003295 industrial effluent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000005060 membrane bound organelle Anatomy 0.000 description 1
- 101150111169 mer gene Proteins 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000033783 photosynthetic electron transport chain Effects 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000010152 pollination Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000003161 proteinsynthetic effect Effects 0.000 description 1
- 101150074945 rbcL gene Proteins 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000007361 sporulation-agar Substances 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 231100001234 toxic pollutant Toxicity 0.000 description 1
- 231100000583 toxicological profile Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8214—Plastid transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8259—Phytoremediation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- This application pertains to the field of genetic engineering of plant genomes, particularly plastids and to methods of and engineered plants with operons that lead to and result in overexpression of the gene of interest. This application also pertains to the field of genetic engineering of algal and bacterial genomes.
- Karamata in U.S. Pat. No. 4,797,279, proposed the generation of Bacillus thuringiensis hybrids that have insecticidal properties through conjugation. Conjugation is mediated by a conjugative plasmid functional in the B.t. kurstaki strain and the B.t. tenebrionis strain. The resulting hybrid is capable of producing each of the delta-endotoxin crystals typical for a B.t. kurstaki strain and a B.t. tenebrionis strain.
- McBride in U.S. Pat. No. 5,545,818 and McBride et. al. (1995), describes a method of genetically engineering the plastids of a plant or plant cell such they provide increased expression of the Bacillus thuringiensis insecticidal proteins in the plastids.
- the transcription and translation of the B.t. gene product occurs in the plastids.
- Daniell et. al. in U.S. Pat. No. 5,932,479 (1999), entitled “Genetic engineering of plant chloroplast,” teaches plant cells chloroplast transformed by means of an expression cassette comprising an exogenous DNA sequence which is stably integrated to the chloroplast genome of the cell of a target plant.
- “Stably” integrated DNA sequences are those which are inherited through genome replication by daughter cells or organisms. This stablility is exhibited by the ability to establish permanent cell lines, clones, or transgenic plants comprised of a population containing the exogenous DNA.
- U.S. Pat. No. 5,693,507 discloses such stable integration of the chloroplast by means of an expression cassette which comprises an exogenous DNA sequence which codes for a desired trait, and the transformed plant.
- Daniell in PCT International Publication WO 99/10513, teaches the composition and use of universal chloroplast integration and expression by vectors to stably transform and integrate genes of interest into chloroplast genome of multiple species of plants. This leads to chloroplast expression of genes of interest. Transformed plants show the highest level of expression. Plants transformed with insecticidal genes are lethal to insects that are 40,000-fold resistant to Bt. insecticidal proteins.
- the prior art inventions use multiple promoters to drive the expression of multiple genes.
- the inventions of the prior art employ a single promoter to drive a single monocistron.
- the present invention employs a single promoter to drive polycistrons, resulting in equal levels of expression of the polycistrons.
- expression of polycistrons via the plastid genome provides a unique opportunity to express entire pathways in a single transformation event.
- chloroplast genetic engineering is an environmentally friendly approach resulting in containment of foreign genes and hyper-expression.
- Plant bioremediation is the use of plants for in-situ restoration of contaminated sites.
- the technique has risen in the last decade as a strong and safe technique to address with the increasing problems of the pollution of soil and water bodies.
- other techniques such as mechanical and bacterial bioremediation were implemented with little success, since they were costly and threatened the safety of our environment.
- Plants are advantageous for bioremediation systems since they have a high capacity for adaptation to different environments and a natural resistance against different toxic pollutants. They are cheap, non-evasive and help contain disrupted ecosystems. These characteristics make plants an ideal vehicle for bioremediation.
- Mercury is a toxic heavy metal that is commonly released into the environment as a byproduct of different chemical reactions of modern industries.
- the present world production of mercury is about 9000 tons/year (http://www.chem.ualberta.cal.htm).
- mercury is rapidly methylated by methanogenic bacteria (Ex. Desulfovibrio desulfuricans ) producing the 10 fold more toxic organomercurials (Compeau et. al.) 1985; Gilmour et. al. 1992).
- Organomercurials are more toxic due to its increased hydrophobicity, which allows it to cross lipid membranes because it is more hydrophobic than mercury.
- mercury pollution also poses a problem.
- Mercury accumulates in the sediments of lakes and oceans where methanogenic bacteria live (http://ehpnet.niehs.nih.gov). These bacteria methylate mercury to produce methylmercury, which is eventually released into water (Harada et al. 1995).
- the methylmercury is trapped into the small fish when the water passes through their gills or they feed on phytoplanktons that carry high concentrations of the pollutant.
- Predatory fish, as bass in fresh water and tuna in salt water live for long periods of time feeding on smaller fish.
- chloroplasts for foreign gene expression, it was not obvious that multiple genes expressed by a single promoter in chloroplasts would be expressed in this organelle in a coordinated manner. Polycistrons have been observed in chloroplasts in the past but processing RNA sequences present in between individual transcripts, proteins or enzymes involved in processing or cofactors necessary for processing of polycistrons have not yet been characterized. Therefore, it was not obvious to one skilled in the art that multiple foreign gene transcripts would be properly processed and translated when expressed from a heterologous promoter.
- chloroplast ribosome binding sites have been characterized, it was not obvious that ribosome binding sites or untranslated regions upstream of bacterial genes would function in plastids. Also, it was not anticipated that a chaperonin present in a bacterial cell would function within chloroplasts and help fold the foreign protein or interfere with folding of other chloroplast proteins. It was certainly unanticipated that it was possible to create cuboidal crystals within chloroplasts duplicating the functions of a bacterium during sporulation or duplicate bioremediation pathways within plastids. There was no certainty that the enzymes of the pathway or proteins of the operon would be expressed in a coordinated manner.
- plastid expression constructs are provided which are useful for genetic engineering of plant cells and which provide for enhanced expression of several foreign proteins in plastids utilizing a single transformation event.
- the transformed plastid is preferably a metabolically active plastid, such as the chloroplasts found in green and non-green plant tissues including leaves and other parts of the plant.
- This invention opens the door to engineering novel pathways for metabolic engineering and gene stacking, or for multi subunit complex proteins requiring stoichiometric and coordinated expression of multiple genes.
- the plastid is preferably one which is maintained at a high copy number in the plant tissue of interest.
- the present invention is applicable to all plastids of plants. These include chromoplasts which are present in the fruits, vegetables and flowers; amyloplasts which are present in tubers like the potato; proplastids in roots; leucoplasts and etioplasts, both of which are present in non-green parts of plants.
- transformation vectors for transfer of the construct into a plant cell include means for inserting the expression and selection constructs into the plastid genome. This preferably comprises regions of homology to the target plastid genome which flank the constructs.
- the chloroplast vector or constructs of the invention preferably include a universal chloroplast expression vector which is capable of importing a desired trait to a target plant species.
- a vector is competent for stably transforming the chloroplast genome of different plant species which comprises an expression cassette which is described further herein.
- Such a vector generally includes a plastid promoter region operative in said plant cells chloroplast, a gene which is linked to a multi-gene operon which includes an ORF which codes for a putative chaperonin which facilitates the folding of the protein to form proteolytically stable cuboidal crystals.
- one or more DNA sequences of interest to be expressed in the transformed plastids are preferred.
- the invention provides also a plastid vector comprising of a DNA construct.
- the DNA construct includes a 5′ part of a plastid DNA sequence inclusive of a spacer sequence; a promoter that is operative in the plastid; at least a heterologous DNA sequence encoding multiple peptides of interest; a gene that confers resistance to a selectable marker; a multi-gene operon; a transcription termination region functional in the target plant cells; and a 3′ part of the plastid DNA sequence inclusive of a spacer sequence.
- the DNA construct is flanked by DNA sequences which are homologous to the spacer sequence of the target plastid genome.
- the plastid is preferably a chloroplast.
- the vector preferably includes a ribosome binding site and a 5′ untranslated region (5′UTR). A promoter operative in the green and non-green plastids is to be used in conjunction with the 5′UTR,
- the invention provides a promoter that is operative in the green and non-green plastids of the target plant cells such as the psbA promoter, rbcL promoter, atp ⁇ promoter region, accD promoter, and the 16SrRNA promoter.
- the invention provides a gene, which can be a mutant gene, that confers resistance, such as antibiotic resistance, to a selectable marker like the aadA gene.
- the invention provides a cassette which can be modified to include a selectable marker, a gene encoding the chaperonin and any desired heterologous gene. Such applications will be beneficial for the high level production in plants of other desired protein products as well
- the invention preferably provides a three-gene insecticidal Bacillus thuringiensis (Bt) operon which shows operon expression and crystal formation via the chloroplast genome.
- the operon comprises of three operably linked components which operate in concert as a biosynthetic pathway: a distal gene which codes for a insecticidal protein and two open reading frames (ORF).
- the two ORFs code for at least one molecule of interest and at least one chaperonin to assist in the folding of the insecticidal protein.
- the molecule of interest of this operon can be a peptide, an enzyme, a selectable marker, or a bio-pharmaceutical, including monoclonals.
- This invention also provides for other three-gene operons, particularly insecticidal operon or the Cry2Aa2 operon. This invention also provides for operons of the Cry or Cyt series.
- An operon of this invention further provides that the second ORF (ORF2) codes for a putative chaperonin.
- a chaperonin is a molecule which facilitates the folding and assembly of proteins to form functional proteolytically stable cuboidal crystals.
- the ORF2 is operably linked to a gene encoding the insecticidal protein.
- the invention provides a bacterial chaperonin that is capable of facilitating the folding and assembly of insecticidal proteins.
- This invention also provides crystallized insecticidal proteins such as ⁇ -endotoxin proteins, Cry proteins such as the Cry2Aa2 proteins, or Cyt proteins.
- the introduction blocks of foreign genes in a single operon would avoid complications inherent in nuclear transformation such as position effect and gene silencing in putting one gene at a time into random locations in the nuclear genome.
- Repeated use of a single promoter causes gene silencing (De Wilte, C. et. al. 2000).
- Cloning several genes into a single T-DNA does not avoid the compounded variable expression problem encountered in nuclear transgenic plants.
- This invention shows that a bacterial operon can be expressed in a single integration event. Expression of multiple genes via a single transformation event opens the possibility of expressing foreign pathways or pharmaceutical proteins involving multiple genes.
- the invention provides for the demonstration of expression of a bacterial operon or polycistrons in transgenic plants and opens the door to engineer novel pathways in plants in a single transformation event.
- the invention provides a single vector or construct (or cassette) which encodes more than one heterologous protein product.
- This embodiment of the invention provides that a heterologous DNA fragment that is introduced into a universal vector encodes more than one gene.
- this invention discloses, the DNA encodes an operon of three genes and produces proteins from at least two genes, one of those genes encode a protein and a chaperone protein.
- another embodiment of the invention relates to the maximal production of a heterologous protein by co-expressing it with another polypeptide that induces crystallization of said protein.
- This aspect of the invention provides the yield of heterologous gene expression is greatly enhanced if the desired protein is in crystal form in the transformed plant. The increased yield is because the crystal form of the proteins protected them from cellular proteases. This is accomplished by co-expressing the desired gene with a second gene encoding a chaperonin that directs crystallization.
- cry2Aa2 operon in chloroplasts provides a model system for hyper-expression of foreign proteins in a folded configuration enhancing their stability and facilitating single step purification. This is the first successful demonstration of expression of a bacterial operon in transgenic chloroplast plants.
- the invention provides a model system for large-scale production of foreign protein within chloroplasts in the folded configuration enhancing their stability and facilitating single-step purification, for example, biopharmaceuticals such as human serum albumin (HSA) and insulin.
- biopharmaceuticals such as human serum albumin (HSA) and insulin.
- All known methods of transformation can be used to introduce the vectors of this invention into target plant plastids including bombardment, PEG Treatment, Agrobacterium , microinjection, etc.
- the invention provides transformed crops, like solanaceous plants (monocotyledonous and dicotyledonous).
- the plants are edible for mammals, including humans.
- the invention provides target Bt transgenic plants which are likely to show a more stable protein expressed at high levels in the chloroplast throughout the growing season. It should increase toxicity of Bt transgenic plants to target insects and help eliminate the development of Bt resistance.
- the invention provides an example of the cry2Aa2 bacterial operon is expressed in tobacco chloroplasts to test the resultant transgenic plants for increased expression and improved persistence of the accumulated insecticidal protein(s).
- the invention provides transformed plants including leaves which accumulated a high percent of total soluble protein (close to 50%) in mature leaves and remain stable even in old bleached leaves.
- the invention provides transformed plants which are resistant to difficult-to-control insects, like cotton boll worm, which were killed 100% after consuming transgenic leaves.
- the invention also provides plants which contain insecticidal protein fold into cuboidal crystals. Plants which contain protoxin crystals, which will be processed only by target insects that have high alkaline gut environment, which should improve safety of Bt transgenic plants. Also, plants are free of insecticidal proteins in transgenic pollen, which eliminates toxicity to non-target insects via pollen such as Monarch butterfly larvae.
- the invention provides electron microscopic proof of the presence of the cuboidal crystals inside the chloroplast.
- the invention also provides an environment friendly approach to engineering insect resistance to plants because folded crystal products improve the safety of the Bt transgenic plants which will be edible consume, mammals, including humans.
- heterologous DNA sequences which mediate resistance to (a) heavy metal in transgenic plants or plant cells which express these coding sequences encoding metal ion reductases and (b) organomercurial compounds in transgenic plants or plant cells which express the coding sequence encoding organomercurylyase.
- the coding sequence is that of merA (which encodes mercuric ion reductase) and merB (which encodes organomercury lyase).
- the present invention provides a chloroplast universal vector which contains a Mer operon containing metal resistance coding sequences operably linked to transcriptional and translational control sequences which are functional in the chloroplast in target plants.
- the coding sequence is that of merA and merB.
- the present invention provides transgenic plant cells, plant tissue and plants whose chloroplast has been modified to contain and express two metal resistance coding sequences operably linked to transcriptional and translational control sequences which are functional in the chloroplast of target plants.
- the coding sequences are that of merA and merB.
- Also provided by the present invention are methods for effecting metal resistance in plants by stably transforming a plant to contain and express two heterologous DNA sequences encoding metal resistance operably linked to transcriptional and translational control sequences which are functional in the chloroplasts of target plants.
- the coding sequence is that of merA and merB.
- the present invention are methods for effecting metal resistance in plants by stably transforming a green algae or cyanobacteria to contain and express two heterologous DNA sequences encoding metal resistance operably linked to transcriptional and translational control sequences which are functional in the target green algae or cyanobacteria.
- the coding sequence is that of merA and merB.
- a further object of the invention are transgenic plants, algae and bacteria which contain and express metal resistance and organomercurial compound resistance coding sequences.
- FIG. 1 shows (a) Chloroplast expression vector pLD-BD Cry2Aa2 operon (9.8 kb) with PCR primer landing sites and expected fragment sizes. PCR analysis of untransformed and putative chloroplast transformants using two primer sets: (b) 1P1M; and (c) 3P3M. Lane 1:1 kb ladder; Lane 2: untransformed; Lanes 3-7: pLD-BD Cry2Aa2 operon putative transformants; Lane 8: pLD-BD Cry2Aa2operon plasmid DNA.
- FIG. 2 shows the Southern blot analysis of T 0 and T 1 generations.
- A The 0.81 kb probe BamH1-Bglll fragment containing the chloroplast flanking sequence. Untransformed plants generate a 4.47 kb fragment.
- B Vector map showing Cry2Aa2 operon transformed 32P labeled fragments of 8.42 kb and 1.42 kb.
- C Lane 1:1 kb ladder; Lane 2: untransformed; Lanes 3-7; T0 transgenic lines; Lanes 8-9: T1 transgenic lines.
- FIG. 3 shows the 10% SDS-PAGE gel stained with R-250 Coornassie Blue. Loaded protein concentrations are provided in parenthesis. Lanes 1: prestained protein standard; Lane 2: partially purified Cry2Aa2 protein from E. Coli (5 ⁇ g); Lane 3: Single Gene derived Cry2Aa2 pellet extract solubilized in 50 mM NaOH (22.4 ⁇ g); Lane 4: Single Gene derived Cry2Aa2 supernatant (66.5 ⁇ g); Lane 5: Operon Derived Cry2Aa2 supernatant (58.6 ⁇ g); Lane 7: untransformed tobacco pellet extract solubilized in 50 mM NaOH (29.8 ⁇ g); Lane 8: untransformed tobacco supernatant (30.4 ⁇ g). Colored compounds observed in the supernatant of transgenic plants interfered with the DC Bio-Rad protein assays but not in the pellet.
- FIG. 4 shows the quantification of Single Gene derived Cry2Aa2 and Operon Derived Cry2Aa2 proteins by ELISA as a percentage of total soluble protein in young, mature, and old transgenic leaves.
- A Single Gene derived Cry2Aa2 expression shown as a percentage of total soluble protein.
- B Operon derived Cry2Aa2 expression shown as a percentage of total soluble protein.
- FIG. 5 shows the insect bioassays of untransformed tobacco leaves (A, D, G), Single Gene derived Cry2Aa2 transformed leaves (B, E, H) and Operon Derived Cry2Aa2 transformed leaves (C, F, I).
- A, B, C bioassays with H. virescens
- D, E, F bioassays with H. zea
- G, H, I bioassays with S. exigua.
- FIG. 6 shows the electron micrographs of Operon Derived Cry2Aa2 leaf sections in young (A), mature (B, D) and old, bleached leaf (C).
- A young
- B mature
- C old, bleached leaf
- E Single Gene derived Cry2Aa2 mature leaf
- F mature untransformed leaf
- FIG. 7 shows the phenotypes of untransformed (A) or transformed with the cry2Aa2 gene (B) or cry2Aa2 operon (C).
- FIG. 8 shows a pLD-merAB chloroplast vector.
- FIG. 9 shows transformed E. Coli grown in 100 ⁇ m HgCl 2 .
- FIG. 10 shows chloroplast transgenic plants.
- A Transgenic plant shoot induction in RMOP with 500 ⁇ g/ml Spec.
- B Transgenic plant root induction in MSO with 500 ⁇ g/ml Spec.
- C Transgenic plant grown in soil.
- FIG. 11 shows integration of the mer operon into the chloroplast genome.
- A PCR using specific primers that land in the gene cassette (5P/2M) show a product of 3.8 kb size (clones2, 4, 5, 7, 9, 11). Clones 1 and 3 show no integration of the cassette. Positive control, is plasmid pLD-merAB-3′UTR. Negative control is untransformed plant DNA.
- B PCR using specific primers that land within the native chloroplast genome (3P/3M), eliminate mutants (clone 3), showing integration of the cassette into the chloroplast genome (clones: 1, 2, 4, 5, 6, 7, 9, 11. 1.6 kb PCR product).
- FIG. 12 shows the Chlorella vulgaris vector construct.
- FIG. 13 shows the Synechocystis vector construct.
- FIG. 14 shows the Lemna vector construct.
- FIG. 15 shows the Sugarcane vector construct.
- FIG. 16 shows confirmation of Lemna vector construct.
- FIG. 17 shows confirmation of Sugarcane vector construct.
- FIG. 18 shows other vectors suitable for operon expression.
- This invention is related to transformation of the plastid genome applicable to all plastids of plants. These include chromoplasts which are present in the fruits, vegetables and flowers; amyloplasts which are present in tubers like the potato; proplastids in roots; leucoplasts and etioplasts, both of which are present in non-green parts of plants
- the invention provides in one aspect a single vector or construct which encodes more than one heterologous protein product.
- the second aspect of the invention relates to the maximal production of a heterologous protein by co-expressing it with another polypeptide or a chaperone that induces crystallization of said protein.
- the first aspect of the invention provides that a heterologous DNA fragment that is introduced into a plastid vector (described below) encodes more than one gene.
- the DNA encodes an operon of three genes and produces proteins from three genes.
- This aspect of the invention to co-expressing multiple genes is beneficial if one desires to introduce a biosynthetic pathway into plants that comprises multiple steps. For example, a three step synthesis of a desired compound might require three different enzymes. Co-expressing all three enzymes in the chloroplast can be accomplished according to this invention. Thus, a single transformation will generate a recombinant plant possessing all three heterologous enzymes which can function in concert to produce the desired product.
- the second aspect of the invention is that the yield of heterologous gene expression is greatly enhanced if the desired protein is in crystal form in the transformed plant, as provided by this invention. This is accomplished by co-expressing the desired gene with a second gene encoding a chaperone protein that directs crystallization. Data given in the specification shows almost 100 fold greater amounts of insecticidal protein can be found in plants co-expressing the chaperone protein versus plants having only the gene encoding the insecticidal protein.
- the expression cassette itself can be modified to include a selectable marker, a gene encoding the chaperone protein and any desired heterologous gene. Such applications will be beneficial for the high level production in plants of other desired protein products as well.
- a further aspect of the invention describes a plant bioremediation system.
- a plant bioremediation system employing chloroplast transformants have a number of advantages. First, plants have the genetic capacity (using hundreds, even thousands, of genes) to extract at least 16 metal cation and oxyanion nutrients from the soil and ground water. This capacity can be chemically and genetically manipulated to extract environmental pollutants. Second, plants have extensive root systems to help in this mining effort; typical estimates are as high as 100 ⁇ 10 6 miles of roots per acre [Dittmer, H. J. (1937) Amer. J. Botany 24:417-420]. The root systems of various macrophytes can reach up to 40 feet into the soil.
- plants are photosynthetic and govern as much as 80% of the available energy at any given time in most ecosystems.
- photosystem I a system not found in photosynthetic bacteria
- they use light energy to generate large amounts of reducing power (as NADPH) that can be used to efficiently reduce metal ions.
- Plants photosynthetically fix CO 2 and reduce it to make their own carbon/energy source. This reduced carbon energy is used by plant roots to live heterotrophically.
- This redox power can also be used to reduce toxic metal ions like Hg(II) [Rugh et al. (1996) supra].
- Many plants can produce large amounts of biomass annually with the potential both to enrich contaminated soil with carbon and nutrients and/or remove metal ions from the soil.
- the site of action of mercury within the chloroplasts, ability to express bacterial operon via the chloroplast genome, and several other environmental benefits of chloroplast genetic engineering make this an advantageous system for metal remediation.
- metal resistant plants are their ability to harvest metals; precious and semi-precious metals can be reduced and thereby trapped in plant tissues.
- metals include can include gold, silver, platinum, rhenium, copper, palladium, nickel, zinc and cadmium, where the corresponding metal ions are reduced by the metal resistance gene product in those plants.
- this invention also introduces a novel approach for mercury and organomercurial bioremediation in water.
- Two organisms are used as model systems.
- One is Synechocystis , a photosynthetic bacterium (Cyanobacterium) that grows in salt and fresh water (in a high temperature range, from ice to hot springs).
- the other is Chlorella vulgaris , a green algae that grows in fresh water.
- These organisms are transformed with the merA and merB genes (mer operon) to remove mercury and organomercurials from water. Transformed cells could be applied for sludge treatment and in water treatment to remove organomercury and mercury form water and sediments before releasing them to the environment, especially from industrial effluents that generate byproducts with mercury.
- Metal resistance means that anon-naturally occurring organism is not inhibited by the presence of at least one of divalent cations of mercury, cadmium, cobalt, trivalent cations of gold, and monovalent silver ion, at concentrations (levels) at which a naturally occurring (wild-type) counterpart of the non-naturally occurring organism is inhibited or exhibits symptoms of toxicity. It is not intended that the term metal resistance refer to resistance to unlimited concentration of metal ions, but rather the term is relative in that it relies on comparison to the properties of a parental strain.
- a “metal resistance coding sequence” is one which encodes a protein capable of mediating resistance to at least one metal ion, including, but not limited to, divalent cations of mercury, nickel, cobalt, trivalent cations of gold, and by monovalent cations of silver. Also within the scope of this definition are mutant sequences which determine proteins capable of mediating resistance to divalent cations of lead, cadmium and copper.
- organomercurial resistance coding sequence is one whose protein product mediates resistance to such organic mercury compounds as alkylmercurials and certain aromatic mercurials, for example, mono- or dimethyl mercury, typically in conjunction with a metal resistance gene such as merA.
- the organomercurial resistance gene is the methylmercury lyase gene (merB) and its gene product confers resistance to organomercurial compounds such as methymercury, p-chloromercuribenzoate (PCMB) and p-hydroxymercuribenzoate in conjunction with the merA gene product (mercury ion reductase).
- the metal resistance protein (MerA protein, mercuric ion reductase) is exemplified by that from Tn21, a bacterial mercury resistance transposon originally isolated from the IncFII plasmid NR1.
- Tn21 a bacterial mercury resistance transposon originally isolated from the IncFII plasmid NR1.
- the Tn21 MerA reduces trivalent gold and monovalent silver cations [Summers and Sugarman (1974) Journal of Bacteriology 119:242-249].
- Monovalent silver and certain divalent metal cations have been shown to be competitive inhibitors of mercuric ion reduction in vitro [Rinderle et al. (1983) Biochemistry 22:869-876].
- MerA mediates resistance to trivalent gold, divalent cobalt, divalent copper and divalent nickel cations as well as divalent ionic mercury.
- nucleic acid sequences from nucleotide 14 through nucleotide 1708, or MerApe 20, MerApe 29, MerApe 38 or MerApe 47 will function as coding sequences synonymous with the exemplified merApe9 coding sequence.
- Nucleic acid sequences are synonymous if the amino acid sequences encoded by those nucleic acid sequences are the same.
- the degeneracy of the genetic code is well known to the art; i.e., for many amino acids, there is more than one nucleotide triplet which serves as the codon for the amino acid; for expression in plant cells or tissue it is desired that codon usage reflect that of plant genes and that CpG dinucleotides be kept low in frequency in the coding sequence.
- merB in plants confers resistance to and/or the ability to detoxify organomercurials including, but not limited to, alkylmercury compounds wherein the alkyl group is either straight chain or branched, alkenyl mercury compounds, allyl mercury, alkynyl mercury compounds, aromatic mercury compounds, wherein there are from one to about 6 aromatic rings, and other organomercurials including but not limited to humic acid-containing mercury compounds.
- organomercurials including, but not limited to, alkylmercury compounds wherein the alkyl group is either straight chain or branched, alkenyl mercury compounds, allyl mercury, alkynyl mercury compounds, aromatic mercury compounds, wherein there are from one to about 6 aromatic rings, and other organomercurials including but not limited to humic acid-containing mercury compounds.
- the MerB protein also mediates resistance to and/or detoxifies organo-metals including, but not limited to, organic lead, organic cadmium and organic arsenic compounds, where those organometals can
- Coding sequences suitable for expression in a plant are operably linked downstream of a constitutive or a regulated promoter construct.
- Transgenic plants can be constructed by use of chloroplast universal vector containing a 5′ a part of a chloroplast spacer sequence, a promoter that is operative in the chloroplast of the target plant cells, at least two heterologous DNA sequences encoding merA and merB, a gene that confers resistance to a selectable marker; a transcription termination region functional in the target plant cells; and a 3′ part of the chloroplast spacer sequence.
- the vector may not contain a terminator.
- the mer operon-expressing plants can be used in the remediation of mercury-contaminated soil to block the biomagnification of methyl mercury up the food chain.
- Deep-rooted trees like cottonwood and sweetgum, which inhabit bottom lands, can be transformed to express mer A and merB. These species have roots that grow in the same general area of the sediment as sulfate-reducing bacteria.
- MerB breaks the carbon mercury bond to produce Hg(II).
- Hg(II) is a highly reactive metal ion and should end up sequestered in plant tissues bound to various thiol groups.
- Hg(II) produced from the MerB reaction and additional Hg(II) taken up from the environment through its normal mining of nutrients is reduced to Hg(0) by the MerA reaction.
- Hg(0) is released directly from the roots or transpired up the vascular system of the plant, as are waste gasses like CO 2 from some plants [Dacey, J. W. (1980) Science 210: 1017-1019; Dacey, J. W. (1981) Ecology 62:1137; Raven et al. (1986) In: Biology of Plants, Worth Publishers, N.Y., p. 775].
- By lowering the total levels in the soil less methyl mercury will be produced by sulfate-reducing bacteria.
- Using the MerA and MerB together in transgenic plants at contaminated sites lowers total Hg(II) levels and destroys environmental methyl mercury, thus preventing a large portion of the methyl mercury from moving through the environment.
- Hg(0) entering the environment joins the enormous and stable pool of Hg(0) in the atmosphere (Nriagu (1979) In: The Biogeochemistry of Mercury in the Environment, (New York: Elsevier) with half life of over one year. Because Hg(0) is not easily returned to earth, this pool is not thought to contribute less significantly to manmade contamination of the environment. In contrast, atmospheric Hg(II) species (i.e., mercury released from coal burning or methyl mercury released naturally) are rapidly returned to earth by rain and dry deposition with a half-life of about 1-2 weeks. Thus, volatilization of relatively small amounts of Hg(0) with good air circulation effectively removes mercury from terrestrial and aquatic environments.
- transgenic plants at this site increased the efflux rate of metallic mercury 200 times, the level of atmospheric mercury would still be 50 fold below these allowable levels.
- the transgenic plants of the present invention allow the efficient removal of toxic metal compounds such as methyl mercury and ionic mercury from soil, sediment, and aquatic environments, thus meeting a longfelt need for efficient bioremediation of metal and organometal contaminated sites.
- the cry2Aa2 Operon The preferred embodiment of the invention is the use of Bacillus thuringiensis (Bt) cry2Aa2 operon as a model system to demonstrate operon expression and crystal formation via the chloroplast genome of tobacco.
- This operon contains three open reading frames (ORFs).
- Cry2Aa2 is the distal gene of this operon.
- the ORF immediately upstream of cry2Aa2 codes for a putative chaperonin that facilitates the folding of cry2Aa2 (and other selected target proteins) to form proteolytically stable cuboidal crystals.
- the function of the third ORF is not yet known.
- the invention comprises the operon with the third gene and also with the operon without the third gene.
- the mer Operon Another embodiment of the invention uses the mer Operon.
- the genes for mercury resistance are known as Mer genes, they are found in operons of bacterial pasmids; different genes constitute operons, but the two most important are: the merA that codes for the mercuric ion reductase and the merB that codes for the organomercurial lyases (Foster, 1983; Summers et al. 1978, 1986).
- Mer A is a 1.7 kb gene that needs NADPH as a co-factor to reduce mercury to a volatile, non-reactive and less toxic form of mercury (Hg0) (Begley et al. 1986).
- Mer B is a 638 bp gene that undergoes the protonolysis of organomercurials by removing the organic group and releasing elemental mercury, which is detoxified by merA (Jackson et al. 1982).
- a polycistron containing both genes allows effective degradation of mercury and organornercurials
- Cry or Cyt operons may be used in this invention. Any operon which comprises at least one of the 133 genes shown in the article MMBR, September 1998, pages 805-873, Vol 62, No. 4, Revision of the Nomenclature for the BT Insecticidal Crystal Proteins by Crickmon et al., the genes of which codes for the corresponding BT protein; and the chaperonin which facilitates protein folding can be used. Likewise, any operon which comprises at least one of the toxins enumerated in Table 15.1 or at least one of the of Molecular Biotechnology by Glick and Pasternak can be used.
- any operon which comprises a gene which codes for a delta-endotoxin and the chaperonin which facilitates protein folding can be used.
- any operon which comprises at least a plasmid identified in Table 13.1 of the of Molecular Biotechnology by Glick and Pasternak can be used.
- Chaperonins are a class of a protein referred to as chaperones which has been shown to consist of helper proteins in chain folding and assembly with the cells (Gierasch and King, 1990). They facilitate the folding and assembly of newly synthesized polypeptide chains into functional three-dimensional structures by preventing off-pathway reactions during folding that lead to aggregation (Agashe V R et. al. 2000). Chaperonins provide a sequestered environment in which folding can proceed unimpaired by intermolecular interactions between non-native polypeptides (Agashe V R et. al. 2000). Those skilled in the art will be familiar with the E. Coli chaperonins: groEL and groES (Viitanen P V et. al.
- the preferred embodiment of this invention use of those bacterial chaperonins that are capable of facilitating the crystallization of the Bt endotoxin polypeptides by means of the UV Ct vector and in the transformed plants.
- This invention contemplates the use of vectors which are capable of stably transforming the chloroplast genome.
- vectors include chloroplast expression vectors such as pUC, pBlueScript, pGEM, and all others identified by Daniell in U.S. Pat. Nos. 5,693,507 and 5,932,479.
- Universal Vector A preferred embodiment of this invention utilizes a universal integration and expression vector competent for stably transforming the chloroplast genome of different plant species (Universal Vector).
- the universal vector and its construction have been described by the earlier Publication No. WO99/10513, International publication date: 4 Mar. 1990, which is herein incorporated in its entirety.
- the 4.0 kb cry2Aa2 operon was inserted into the universal chloroplast expression vector pLD CtV2 (5.8 kb) to form the final E. coli and tobacco shuttle vector pLD-BD Cry2Aa2 operon (9.8 kb) ( FIG. 1A ).
- This vector could be used to transform chloroplast genomes of several plant species because the flanking sequences are highly conserved among higher plants.
- This vector contains the 16S rRNA promoter (Prrn) driving the aadA gene (aminoglycoside 3′-adenylyltransferase) for spectinomycin selection and the three genes of the cry2Aa2 operon.
- the terminator is the psbA 3′ region from the tobacco chloroplast genome from a gene coding for the photosystem II reaction center component.
- the 16S rRNA promoter is one of the strong chloroplast promoters recognized by both nuclear and plastid encoded RNA polymerases in tobacco and the psbA 3′ region stabilizes the transcript of foreign genes.
- This construct integrates both genes into the spacer region between the chloroplast transfer RNA genes coding for isoleucine and alanine within the inverted repeat (IR) region of the chloroplast genome by homologous recombination. The integration into these transcribed spacer regions allow the gene to be inserted without interfering with gene coding regions.
- each genome will contain two gene copies due to integration into the two inverted repeat regions resulting in a higher copy number (7,000-8,000 copies per cell) and higher levels of expression.
- the two genes may also be integrated outside of the IR region resulting in a lower copy number. Chloroplast transgenic plants were obtained as described previously by Daniell (1993, 1997).
- both genes (merB and merA) in-frame were ready for insertion into the pLD vector.
- the merB-merA cassette extracted from the TA-vector was ligated into the pLD vector ( FIG. 8 ). The final step was to check for correct orientation.
- the pLD-merAB vector lacking 3′ UTR was constructed.
- pLD-merA.B-3′UTR specific set of primers were used to amplify the whole cassette from the TA-merAB vector.
- the 5′ primer was designed with an EcoRV site and the 3′ primer with a XbaI site. These restriction sites allowed the integration into the pLD vector only in the right orientation.
- FIGS. 1 A,B,C Foreign gene integration into the chloroplast genome was determined by PCR screening of chloroplast transformants.
- Primers were designed to eliminate spectinomycin mutants and nuclear integration.
- the first primer set, 1P1M lands one primer (1P) on the 3′ end of the 16s rRNA flanking sequence and another primer (1M) on aadA ( FIG. 1A ). This is to distinguish between spectinomycin mutants and true spectinomycin transformants.
- a 1.6 kb fragment is seen in true transformants ( FIG. 1B , lanes 3, 5, 6, 7).
- Lane 4 shows a spectinomycin mutant with no PCR product.
- Untransformed tobacco DNA (lane 2) expectedly shows no product, while pLD-BD cry2Aa2 operon plasmid DNA in lane 8 produced the 1.6 kb fragment.
- the second primer set, 3P3M lands one primer (3P) on the native chloroplast genome adjacent to the point of integration, and another primer (3M) on the aadA gene ( FIG. 1A ).
- This primer set generated a 1.65 kb PCR product in chloroplast transformants ( FIG. 1C , lanes 3, 5, 6, 7).
- Untransformed tobacco DNA (lane 2) showed no PCR product, and pLD-BD cry2Aa2 operon plasmid DNA in lane 8 also showed no PCR product because 3P lands on native chloroplast DNA.
- Lane 4 was negative for chloroplast integration and again proving this transformant to be a spectinomycin mutant.
- T 0 plant DNA also shows this native untransformed 4.47 kb fragment ( FIG. 2C , lanes 3-7), thereby showing heteroplasmy in the T 0 generation.
- This 4.47 kb native band is absent from the T 1 generation ( FIG. 2C , lanes 8-9), thus indicating homoplasmy. If only a fraction of the genomes were transformed, the gene copy number should be less than 8,000 per cell. Confirmation of homoplasmy in T 1 transgenic lines indicates that the Cry2Aa2 operon gene copy number could be as many as 7000-8,000 per cell.
- CRY2Aa2 protein expression and quantification Expression profile of the operon derived (OD) Cry2Aa2 and single gene derived (SG) Cry2Aa21 is shown on a Coomassie stained SDS-PAGE gel ( FIG. 3 ). The primary goal of this experiment is to investigate the location of the operon derived Cry2Aa2 protein (the pellet or supernatant) and correlate with cuboidal crystals observed in electron micrographs (see FIG. 6 ). Lane 2 contains partially purified 65 KD Cry2Aa2 from E. coli .
- Cry 2Aa2 polypeptides ( FIG. 3 , lanes 3, 5) were scanned using Storm 840 Gel Scanner and Image Quant Software (Molecular Dynamics). The operon-derived expression results only in a 2.5 fold more accumulation of Cry2Aa2 than that of single gene derived cry2Aa2 in the pellet fraction; this does not correlate with more than 100 fold difference observed in ELISA ( FIG. 4 ). The reason for this discrepancy is the extreme difference in solubilization between SG Cry2Aa2 derived amorphous inclusion bodies and the OD Cry2Aa2 derived cuboidal crystals, as reported previously.
- cry2Aa2 operon derived expression levels are comparable to that of the RuBis Co, the most abundant protein on earth that compromises up to 65% of leaf soluble protein.
- Figures A-C show developmental OD Cry2Aa2 in chloroplasts in young, mature, and old leaves, respectively.
- a young green OD Cry2Aa2 transgenic leaf FIG. 6A
- labeled Cry2Aa2 occupies a significant amount of the chloroplast, but no crystalline structures are observed.
- a mature green OD Cry2Aa2 transgenic leaf FIG. 6B
- labeled Cry2Aa2 occupies a larger amount of the chloroplast than the younger leaf, resulting in crystals.
- Theses cuboidal crystals are essentially identical to those expressed in wild-type Cry2Aa2 crystals, or recombinantly in Bt or E coli .
- OD Cry2Aa2 In an old bleached OD Cry2Aa2 transgenic leaf ( FIG. 6C ), labeled Cry2Aa2 maintains the crystalline structure and occupies the highest volume of the chloroplast observed, despite being bleached and senescent. These findings correlate with OD Cry2Aa2 ELISA results. In young developing leaves, OD Cry2Aa2 begins accumulation (34.9%), folds Cry2Aa2 into a cuboidal configuration in mature leaves occupying more cell volume (45.3%), and maintains this cuboidal structure and volume in old leaves (46.1%). Essentially, as the transgenic OD Cry2Aa2 plant ages, OD Cry2Aa2 is accumulated, folded and maintained.
- FIG. 6D is a mature green OD Cry2Aa2 transgenic leaf showing crystal formation with no immunogold label. This probably occurs because as the Cry2Aa2 is folded by the putative chaperonin, epitopes are concealed thereby decreasing labeling. Crystal formation in FIG. 6D would cause the OD Cry2Aa2 to pellet after centrifugation as seen in SDS-PAGE FIG. 3 (lane 5).
- FIG. 6E In EM analysis of mature leaves expressing SG Cry2Aa2 ( FIG. 6E ), protein aggregation is observed, although no crystalline folding is seen.
- Cry2Aa2 immunogold labeling occurs in an area of much lower density than is seen in OD Cry2Aa2 transgenic plants suggesting lower expression. These results also correlate with ELISA (0.36% in SG Cry2Aa2 in mature leaves). There is no localized antibody observed in untransformed tobacco ( FIG. 6F ).
- Transgenic phenotypes Phenotypes of OD Cry2Aa2 transgenic plants are not morphologically different from SG Cry2Aa2 transgenic plants ( FIG. 7 ). Therefore, higher levels of expression and accumulation of CRY proteins did not visibly impact their phenotype. Both transgenic plants flowered and set seeds. Characterization of OD Cry2Aa2 T. transgenic plants for stable integration and transmission of foreign genes has been shown earlier ( FIG. 2 ).
- This invention enables expression of polycistrons in the chloroplast genome.
- the present invention allows for this achievement in a single transformation event that is environmentally safe.
- the invention thus opens the possibility for gene pyramiding: the insertion of multiple insecticidal genes.
- the invention contemplates operons which include not only Bacillus thuringiensis (B.t.) insecticidal toxin genes, but also non-B.t. insecticidal toxin genes such as cholesteral oxidase, alpha-amylase inhibitors, protease inhibitors, the cowpea trypsin inhibitors, and the potato proteinase inhibitor II. Inclusion of multiple heterologous insecticidal toxin genes retards the ability of insects to develop resistance to bio-pesticides.
- this invention provides a method of engineering biological pathways into the chloroplast genome in a single transformation event that is environmentally safe. Because gene expression is controlled by one promoter, DNA sequences encoding the different genes necessary in a pathway can be co-expressed to the same levels. Once expressed, the genes of the pathway can act in concert. Gene expression can result in synthesis of enzymes that confer desired traits such as degradation of metal ions, herbicides, pesticides, solvents, toulene, napthalene, and other xenobiotics. An example is the chloroplast transformation of plant chloroplasts with the Mer operon leading to the biodegradation of mercury and organomercurials.
- pathways include the pigment biosynthesis pathway, biosynthetic pathways for enzymes that are could confer desired traits such as degradation of xenobiotic compounds noted above, pathways for amino acids such as the lysine biosynthetic pathway, and pathways for the synthesis of vitamins, carbohydrates, fatty acids, biopolymers and polyesters. Further examples are provided in chapters 12 and 13 of Molecular Biotechnology by Glick and Pasternak, which is herein incorporated by reference.
- Other xenobiotics which can be degraded using the system of this invention include those given in U.S. Pat. No. 4,259,444 to Chakrabarty which is herein incorporated by reference.
- polycistrons also opens up the possibility of efficiently expressing bio-pharmaceuticals such as monoclonal antibodies.
- bio-pharmaceuticals such as monoclonal antibodies.
- Those skilled in the art will know the four DNA sequences encoding proteins necessary to compose the molecule. Those skilled in the art will also know that these proteins should be produced in equal amounts (the same stoichiometric ratio).
- the PCT application entitled “Production of Antibodies in Transgenic Plastids,” filed on Feb. 28, 2001 by Daniell, is hereby incorporated by reference to offer examples of such proteins.
- This invention allows for the coordinated expression of these sequences because they are driven by the same promoter. This method avoids the problems of the prior art; namely the pitfalls of nuclear transformation such as the positional effect and gene silencing.
- This invention provides any higher plants, such as monocotyledonous and dicotyledonous plant species.
- the plants that may be transformed via the universal vector with an antibiotic selectable marker may be solanacious plants or plants that grow underground.
- this invention is applicable to the major economically important crops such as maize, rice, soybean, wheat, and cotton.
- a non-exclusive list of examples of higher plants which may be so transformed include cereals such as barley, corn, oat, rice, and wheat; melons such as cucumber, muskmelon, and watermelon; legumes such as bean, cowpea, pea, peanut; oil crops such as canola and soybean; solanaceous plants such as tobacco; tuber crops such as potato and sweet potato; and vegetables like tomato, pepper and radish; fruits such as pear, grape, peach, plum, banana, apple and strawberry; fiber crops like the Gossypium genus such as cotton, flax and hemp; and other plants such as beet, cotton, coffee, radish, commercial flowing plants, such as carnation and roses; grasses, such as sugar cane or turfgrass; evergreen trees such as fir, spruce, and pine, and deciduous trees, such as maple and oak.
- cereals such as barley, corn, oat, rice, and wheat
- melons such as cucumber, muskmelon, and water
- Tobacco plants were grown aseptically under fluorescent lights in the laboratory. Seeds were germinated on MSO medium at 27° C. with photoperiods of 16 hour light and 8 hour dark. Microcarriers coated with pLD-BD Cry2Aa2 operon DNA was used to bombard sterile leaves using the Bio-Rad PDS-1000/He biolistic device as described by Daniell (1997). Bombarded leaves were subjected to two rounds of selection on RMOP medium containing 500 ⁇ g/ml of spectinomycin to regenerate transformants.
- PCR Analysis DNA was extracted from leaves using the QIAGEN DNeasy Plant Mini Kit. PCR was done using the Perkin Elmer Gene Amp PCR System 2400. All PCR reactions were performed using the Qiagen Taq DNA Polymerase Kit. Primer sequences used were: 1P (5′-ACAATGTAGCCGTACTGGA AGGTGCG GGTG-3′), 1M (5′-CGCGCTT AGC TGGATAACGCCACGGAA-3′), 3P (5′-AAAA CCCGTCCTCA GTTCGGATTGC-3′), and 3M (5′-CCGCGTTGTTTCATCAA GCCTTACG-3′). Samples were run for 30 cycles with the following sequence: 94° C. for 1 minute, 70° C. for 1.5 minutes, and 72° C. for 3 minutes. PCR products were separated on 0.8% agarose gels.
- Southern Blot Analysis DNA from transformed and untransformed plants was digested with BgIII and transferred to a nylon membrane by capillary action.
- the 0.81 kb probe was generated by digesting pLD-CtV2 vector DNA with BamH1/BgIII and labeled with 32 P using the ProbeQuantTM G-50 Micro Columns (Amersham). Labeled probe was hybridized with the nylon membrane using the Stratagene QUICK-HYB hybridization solution and protocol.
- ELISA A Cry2Aa2 plate kit from Envirologix was used. Leaves expressing the SG Cry2Aa2, the OD Cry2Aa2, and untransformed tobacco were quantified and compared. Approximately 20 mg of leaf was ground in 100 ⁇ l of 50 mM NaOH to solubilize CRY proteins. Transgenic leaf extracts were diluted to fit in the linear range of the provided Cry2aA2 standard. The ⁇ Quant microtiter plate reader from Bio-Tek read the plate at 450 nanometers (nm). A 1 ppm Cry2Aa2 standard was supplied by the kit and was used in the linear range between 200-1000 ng for quantification. Color development is proportional to Cry2Aa2 concentration in the sample extract. The DC protein assay by Bio-Rad was used to determine total soluble protein concentration as followed by protocol.
- Insect Bioassays Leaf disc bioassays were conducted on ca. 2 cm 2 excised leaf material, and placed on distilled water-soaked cardboard lids in 50 ⁇ 12 mm plastic petri dishes. Insects used were susceptible H. virescens (YDK) obtained from Fred Gould, North Carolina State University, H. zea obtained from the USDA AIRS facility in Tifton, Ga. and S. exigua from the lab of William Moar. Insects were tested as five day or ten day old. All larvae were reared on typical lepidopteran artificial diet prior to use. Two insects were assayed per leaf sample, except H.
- Immunogold labeled electron microscopy was performed as described by A. J. Vrekleij et. al. Sections were first incubated with 0.05M glycine in PBS buffer (10 mM phosphate buffer, 150 mM NaCl pH 7.4) for 15 minutes to inactivate residual aldehyde groups. The grids were then blocked by placing them onto drops of PBS with 5% BSA and 0.1% CWFS gelatin supplemented with 5% normal serum for 30 minutes, washed on drops of incubation buffer 3 times for 5 min each, and then incubated for 45 min with the polyclonal Cry2Aa2 to detect tobacco expression (diluted 1:10,000 in incubation buffer).
- sections were washed on drops of incubation buffer 6 ⁇ 5 min each. Sections were then incubated for 2 hours with a goat anti-rabbit IgG secondary antibody conjugate to 10 nm gold diluted 1:100 in incubation buffer. Sections were subsequently washed 6 ⁇ 5 minutes in incubation buffer, 3 ⁇ 5 min with PBS, and post-fixed in 2% glutaraldehyde diluted in PBS for 5 min. Following post-fixation, sections were washed in PBS 3 ⁇ 5 minutes, in distilled water 5 ⁇ 2 min each, and post-stained using uranylacetate and lead citrate. Sections were then examined in a Zeiss EM 10 transmission electron microscope at 60 kv.
- E. Coli Transformants Due to the similarity of protein synthetic machinery (Brixey et al. 1997), expression of all metal resistance conferring chloroplast vectors are first tested in E. coli before their use in tobacco transformation. The activity of the enzymes, mercury ion reductase (merA) and organomercurial lyase (merB) are tested by transforming E. coli (XLI-blue) with the recombinant plasmids and growing them in LB solid medium with HgCl 2 ( FIG. 9 ). The cells, control (XLI-blue), pLD-merAB and pLDmerAB-3′UTR are grown in different concentrations of Hg Cl 2 .
- XLI-blue mercury ion reductase
- merB organomercurial lyase
- Control cells do not grow even at concentrations less than 25 ⁇ M Hg Cl 2 but the transformed cells grow well even at 100 ⁇ M HgCl 2 -( FIG. 10 ).
- Control and transformed clones are grown in LB with 500 ⁇ g/rnl of spectinomycin for 24 hours at 37′ C. When OD 600 is measured, 1.247 for the clone with 3′ UTR, 0.165 for the clone lacking the 3′ UTR, and zero absorbance for the control is observed.
- the pLD-merAB-3′UTR transformed clone shows a higher growth rate probably caused by the 3′ effective termination which allows cells to make more copies of the mer operon transcript that contain only the aadA, merA and merB genes.
- the terminator of the genes close to the cassette and downstream can serve as a terminator, once it is integrated in the chloroplast genome by homologous recombination.
- Tobacco Nicotiana tabacum var. Petit Havana
- Tobacco Nicotiana tabacum var. Petit Havana
- Plants are grown aseptically by germination of seeds on MSO medium (Daniell 1993). Fully expanded, dark green leaves of about two month old plants are bombarded as described by Daniell (1997). The plants are maintained under 500 ⁇ g/ml spectinomycin selection in the three phases; first selection (RMOP medium), second round of selection (RMOP medium) and third selection MSO (rooting medium) ( FIG. 10 ). After these selection events, positive transformants are transferred to soil ( FIG. 10 ). The plants are tested for integration of the genes in the chloroplast at first round of selection and before transplanting them to soil.
- PCR with specific primers that land in the chloroplast genome and in the gene cassette allows us to eliminate mutants and show integration of the selectable marker gene and the mer genes ( FIG. 11 ). After PCR testing, the plants are grown in soil and the seeds are collected.
- PCR is done using DNA isolated from control and transgenic plants to distinguish a) true chloroplast transfomants from mutants and b) chloroplast transformants from nuclear transformants.
- Primers for testing the presence of the aadA (a gene that confers spectinomycin resistance) in transgenic plants are landed on the aadA coding sequence and 16S rRNA gene primers 1IP&1M).
- aadA a gene that confers spectinomycin resistance
- 16S rRNA gene primers 1IP&1M
- one primer is landed on the aadA gene while another is landed on the native chloroplast genome (primers 3P&3M). No PCR product is obtained with nuclear transgenic plants using this set of primers.
- the primer set (5P & 2M) is used to test integration of the entire gene cassette without any internal deletion or looping out during homologous recombination, by landing on the respective recombination sites. This screening is essential to eliminate mutants and nuclear transformants.
- total DNA from unbombarded and transgenic plants are isolated as described by Edwards et al. (1991). Chloroplast transgenic plants containing the mer gene are moved to second round of selection in order to achieve homoplasmy.
- Southern Blot Analysis Southern blots are done to determine the copy number of the introduced foreign gene per cell as well as to test homoplasmy. There are several thousand copies of the chloroplast genome present in each plant cell. Therefore, when foreign genes are inserted into the chloroplast genome, it is possible that some of the chloroplast genomes have foreign genes integrated while others remain as the wild type (heteroplasmy). Therefore, in order to ensure that only the transformed genome exists in cells of transgenic plants (homoplasmy), the selection process is continued. In order to confirm that the wild type genome does not exist at the end of the selection cycle, total DNA from transgenic plants is probed with the chloroplast border (flanking) sequences (the trnI-trnA fragment).
- flanking sequences Presence of a large fragment (due to insertion of foreign genes within the flanking sequences) and absence of the native small fragment should confirm homoplasmy (Daniell et al., 1998; Kota et al., 1999; Guda et al., 2000).
- the copy number of the integrated gene is determined by establishing homoplasmy for the transgenic chloroplast genome.
- Tobacco Chloroplasts contain 5000-10,000 copies of their genoine per cell (Daniell et al. 1998). If only a fraction of the genomes are actually transformed, the copy number, by default, must be less than 10,000.
- the merAB inserted transformed genome is the only one present, one could establish that the copy number is 5000-10,000 per cell. This is done by digesting the total DNA with a suitable restriction enzyme and probing with the flanking sequences that enable homologous recombination into the chloroplast genome. The native fragment present in the control should be absent in the transgenics.
- Northern Blots are done to test the efficiency of transcription of the merAB operon.
- Total RNA is isolated from 150 mg of frozen leaves by using the “Rneasy Plant Total RNA Isolation Kit” (Qiagen Inc., Chatsworth, Calif.).
- RNA (10-40 ⁇ g) is denatured by formaldehyde treatment, separated on a 1.2% agarose gel in the presence of formaldehyde and transferred to a nitrocellulose membrane (MSI) as described in Sambrook et al. (1989).
- Probe DNA (merAB gene coding region) is labeled by the random-primed method (Promega) with 32 P-dCTP isotope.
- the blot is pre-hybridized, hybridized and washed as described above for southern blot analysis.
- Transcript levels are quantified by the Molecular Analyst Program using the GS-700 Imaging Densitometer (Bio-Rad, Hercules, Calif.).
- Germination/Growth Seeds of wild-type ( Nicotiana tabacum var Petit Havana ), transgenic plant pLD-MerAB, and transgenic plant pLD-MerAB-3′UTR are sterilized, vernalized at 4′ C for at least 24 h, and germinated on 1% Phytoagar plates (GIBCO/BRL) made with Murashige and Skoog (4.3 g/liter, GIBCO/BRL) medium containing PMA (phenylmercuric acetate) or mercuric chloride. Seedlings are grown at 22° C. with a 16 h light/8 h dark period.
- Mercury Vapor Assays Elemental mercury is relatively insoluble and volatile and lost quickly from cells and media. Volatilized Hg 0 is measured on a Jerome 431 mercury vapor analyzer (Arizona Instrument, Phoeniz, Ariz.) (Rugh, C. L. et al., 1996). Approximately 5-10 seedlings (10-14 day old, 10-25 mg total wet weight) are incubated in 2 ml of assay medium (50 mm Tris.HCL, pH 6.8/50 mM NaCl/25 uM HgCl 2 ) in a 16 ⁇ 130 mm test tube with a side arm for gas removal. The Hg Cl 2 is added to initiate the assay.
- assay medium 50 mm Tris.HCL, pH 6.8/50 mM NaCl/25 uM HgCl 2
- the amount of Hg 0 produced is assayed by bubbling air through the bottom of the sample for 12 sec at 3 cm 3 /sec and measuring the release of Hg 0 .
- the time zero assay will be taken immediately after the seedlings are placed in the medium.
- the sample is then reassayed every minute for 10 minutes.
- the volatilized Hg 0 is measured by passing the air sample released from the side arm directly over the gold foil membrane resistor of a Jerome 431 mercury vapor analyzer.
- the instrument is repeatedly standardized with known quantities of Hg 0 (10-200 ng), reduced from HgCl 2 with excess SnCl 2 .
- the amount of mercury evolved is normalized by dividing the number of nanograms of Hg 0 measured by the number of milligrams of seedling tissue in the assay.
- Photosynthetic studies From transgenic plants and untransformed plants, intact chloroplasts are isolated for photosynthetic studies. O 2 evolution is studied in an oxygen evolution electrode in the absence or presence of different concentrations of HgCl 2 and PMA. Electron transport is studied with suitable electron donors/acceptors to study photosystem I, II or both. PAGE is used to examine the composition of PSII complex, especially EP33, after incubation of cells or chloroplasts or thylakoid membranes with different concentrations of HgCl 2 and PMA. In vivo chloroplast fluorescence is studied to monitor changes in control and transformed cells or chloroplasts to measure Fo, Fm, Fv.
- Homoplasmy is indicated by totally green seedlings (Daniell et al., 1998) while heteroplasmy is displayed by variegated leaves (lack of pigmentation, Svab & -Maliga, 1993). Lack of variation in chlorophyll pigmentation among progeny also underscores the absence of position effect, an artifact of nuclear transformation. Maternal inheritance is demonstrated by sole transmission of introduced genes via seed generated on transgenic plants, regardless of pollen source (green seedlings on selective media). When transgenic pollen is used for pollination of control plants, resultant progeny would not contain resistance to chemical in selective media (will appear bleached; Svab and Maliga, 1993). Molecular analyses confirms transmission and expression of introduced genes, and T2 seed are generated from those confirmed plants by the analyses described above.
- Chlorella vulgaris transformation vector The region 16S to 23S of the Chlorella vulgaris chloroplast genome is amplified by PCR using specific primers complementary to rrn16 and to rrn23. The PCR product will be cloned into pCR 2.1 vector available from Promega. The PCR product 16S to 23S is removed from the pCR2.1 vector by a blunt end restriction endonuclease and cloned into the pUC19 in which the multiple cloning site has been removed using a blunt end restriction enzyme (Pvu1I).
- Pvu1I blunt end restriction enzyme
- the cassette containing the promoter, the antibiotic resistance gene and the merAB genes is inserted into the new vector (Chlorella transformation vector) using a blunt end restriction enzyme (HincII) that is present in the spacer region between trnA and trnT.
- the final construct is used for the transformation of Chlorella vulgaris ( FIG. 12 ).
- Chlorella vulgaris The biolistic transformation method (Sanford et al. 1993) is optimized for transformation of Chlorella vulgaris. Chlorella is grown in liquid heterotrophic medium (5 sporulation agar) at 25° C. to late-log phase ( ⁇ 6 ⁇ 10 6 cells/ml). To prepare a monolayer for bombardment (2 ⁇ 10 7 ), cells are collected onto prewetted 45 mm GVWP filters (Millipore) under gentle (30 mbar) vacuum. Gold particles are coated with the transforming plasmid. (Sanford et al. 1993) The monolayer filters are bombarded.
- filters are transferred to selective solid media containing 500 ⁇ g/ml spectinomycin and incubated at 22° C. under high light. After approximately 6 weeks, green colonies are picked from a background of bleached cells onto selective plates and grown for an additional 1-2 weeks. Colonies are harvested and screened for integration of foreign genes when they reached a diameter of approximately 5 mm.
- Chlorella vulgaris Bioassays Growth and colonies formation bioassay are performed as explained in the plant germination growth experiment; the only change is the use of Chlorella specific media.
- Mercury vapor assays are performed in the way explained for plants above except changing the growth media specific to Chlorella , including temperature and light intensity.
- Photosynthetic studies are performed in the way explained for plants above except untransformed and transformed Chlorella cells will be directly used to study the effect of mercury toxicity.
- Synechocystis transformation vector The region 16S to 23S of the Synechocystis genome is amplified by PCR using specific primers complementary to rrn116 and to rrn23. The PCR product is cloned into the pCR2.1 vector available from Promega. The PCR product 16S to 23S is removed from the pCR2.1 vector by a blunt end restriction endonuclease and cloned into pUC19 in which the multiple cloning site has been removed using a blunt end restriction enzyme (Pvu1I).
- Pvu1I blunt end restriction enzyme
- the cassette containing the promoter, the antibiotic resistance gene and the merAB genes is inserted into the new vector (Synechocystis transformation vector) using a blunt end restriction enzyme (HincII) that is present in the spacer region between trnI and trnA.
- HicII blunt end restriction enzyme
- Synechocystis Bioassays Growth and colonies formation bioassay are performed as explained in the plant germination-growth experiment; the only change is the use Synechocystis growth media.
- Mercury vapor assays are performed in the way explained for plants above except changing the growth media specific to the Synechocystis , including temperature and light intensity.
- Photosynthetic studies are performed in the way explained for plants above except untransformed and transformed Synechocystis cells are directly used to study the effect of mercury toxicity.
- Lemna transformation vector The Lemna chloroplast vector, as shown in FIG. 14 , is constructed in the same way as explained above for tobacco, with the exception that the Lemna chloroplast DNA flanking sequences are used.
- Lemna plants are transformed and regenerated in the way explained for tobacco in Example 1 above.
- Plant Bioassays Various plant bioassays are performed as explained for tobacco in Example 1 above.
- the Sugarcane chloroplast vector as shown in FIG. 15 , is constructed in the same way as explained above for tobacco, with the exception that the Sugarcane chloroplast DNA flanking sequences are used.
- Plant Bioassays Various plant bioassays are performed as explained for tobacco in Example 1 above.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Insects & Arthropods (AREA)
- Pest Control & Pesticides (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates in part to a tobacco chloroplast transformation vector effective for stably transforming a tobacco plant to express a multi-gene operon.
Description
- This patent application claims the benefit of U.S. Provisional Applications No. 60/185,660, filed Feb. 29, 2000, 60/257,408, filed Dec. 22, 2000, 60/259,248 filed Dec. 29, 2000 and 60/266,121 filed Feb. 2, 2001. All applications are here incorporated by reference.
- The work of this invention is supported in part by the USDA-NRICGP grants 95-82770, 97-35504 and 98-0185 to Henry Daniell.
- This application pertains to the field of genetic engineering of plant genomes, particularly plastids and to methods of and engineered plants with operons that lead to and result in overexpression of the gene of interest. This application also pertains to the field of genetic engineering of algal and bacterial genomes.
- Karamata, in U.S. Pat. No. 4,797,279, proposed the generation of Bacillus thuringiensis hybrids that have insecticidal properties through conjugation. Conjugation is mediated by a conjugative plasmid functional in the B.t. kurstaki strain and the B.t. tenebrionis strain. The resulting hybrid is capable of producing each of the delta-endotoxin crystals typical for a B.t. kurstaki strain and a B.t. tenebrionis strain.
- McBride, in U.S. Pat. No. 5,545,818 and McBride et. al. (1995), describes a method of genetically engineering the plastids of a plant or plant cell such they provide increased expression of the Bacillus thuringiensis insecticidal proteins in the plastids. A construct containing a promoter functional in plant plastids, a single gene encoding an insecticidal Bacillus thuringiensis toxin, another DNA sequence encoding a selectable marker, and a transcription termination region capable of terminating transcription in a plant plastid, is used to affect plant transformation. The transcription and translation of the B.t. gene product occurs in the plastids.
- Daniell et. al., in U.S. Pat. No. 5,932,479 (1999), entitled “Genetic engineering of plant chloroplast,” teaches plant cells chloroplast transformed by means of an expression cassette comprising an exogenous DNA sequence which is stably integrated to the chloroplast genome of the cell of a target plant. “Stably” integrated DNA sequences are those which are inherited through genome replication by daughter cells or organisms. This stablility is exhibited by the ability to establish permanent cell lines, clones, or transgenic plants comprised of a population containing the exogenous DNA.
- Likewise, U.S. Pat. No. 5,693,507 (1997) to Daniell and McFadden discloses such stable integration of the chloroplast by means of an expression cassette which comprises an exogenous DNA sequence which codes for a desired trait, and the transformed plant.
- Daniell, in PCT International Publication WO 99/10513, teaches the composition and use of universal chloroplast integration and expression by vectors to stably transform and integrate genes of interest into chloroplast genome of multiple species of plants. This leads to chloroplast expression of genes of interest. Transformed plants show the highest level of expression. Plants transformed with insecticidal genes are lethal to insects that are 40,000-fold resistant to Bt. insecticidal proteins.
- Significantly, in the prior art inventions use multiple promoters to drive the expression of multiple genes. Put differently, the inventions of the prior art employ a single promoter to drive a single monocistron. In contrast, the present invention employs a single promoter to drive polycistrons, resulting in equal levels of expression of the polycistrons.
- All publications and patents are hereby incorporated by reference.
- In plant and animal cells, nuclear mRNAs are translated monocistronically. This poses a serious problem when engineering multiple genes in plants. Therefore, in order to express the polyhydroxybutyrate polymer or Guy's 13 antibody, single genes were first introduced into individual transgenic plants, then these plants were back-crossed to reconstitute the entire pathway or the complete protein. Similarly, in a seven year-long effort, Ye et. al. recently introduced a set of three genes for a short biosynthetic pathway that resulted in β-carotene expression in rice. In contrast, most chloroplast genes of higher plants are co-transcribed. Multiple steps of chloroplast mRNA processing are involved in the formation of mature mRNAs.
- In accordance of the invention expression of polycistrons via the plastid genome, in particular the chloroplast genome, provides a unique opportunity to express entire pathways in a single transformation event. Additionally, chloroplast genetic engineering is an environmentally friendly approach resulting in containment of foreign genes and hyper-expression.
- Plant bioremediation (phytoremediation), is the use of plants for in-situ restoration of contaminated sites. The technique has risen in the last decade as a strong and safe technique to address with the increasing problems of the pollution of soil and water bodies. In the past other techniques, such as mechanical and bacterial bioremediation were implemented with little success, since they were costly and threatened the safety of our environment. Plants, on the other hand, are advantageous for bioremediation systems since they have a high capacity for adaptation to different environments and a natural resistance against different toxic pollutants. They are cheap, non-evasive and help contain disrupted ecosystems. These characteristics make plants an ideal vehicle for bioremediation.
- Mercury is a toxic heavy metal that is commonly released into the environment as a byproduct of different chemical reactions of modern industries. The present world production of mercury is about 9000 tons/year (http://www.chem.ualberta.cal.htm). In the environment, mercury is rapidly methylated by methanogenic bacteria (Ex. Desulfovibrio desulfuricans) producing the 10 fold more toxic organomercurials (Compeau et. al.) 1985; Gilmour et. al. 1992). Organomercurials are more toxic due to its increased hydrophobicity, which allows it to cross lipid membranes because it is more hydrophobic than mercury. Over 90% of the intake of methylmercury is absorbed into blood compared with only 2% of inorganic mercury (http://www.chem.ualberta.cal.htm). Both organomercurials and mercury have the tendency to accumulate in the tissue, especially in the membrane bound organelles. In plants organic mercury crosses the lipid membrane of organelles, for example chloroplast, where it can poison essential oxidative and photosynthetic electron transport chains more easily than metallic mercury (Rugh et. al. 1996). In photosynthetic organisms, mercury affects the oxygen-evolving complex that is found in the photosystem II and is bound to the thylakoid membrane (Bernier et al. 1993). Mercury treatment of PSII leads to a strong inhibition of oxygen evolution by removal of EP33 (one of the proteins of the OEE complex; Bernier et al. 1995). Mercury reduces the Fm and Fv values due to additional inhibitory sites on the donor side of PSII, including damage to the light-photochemistry (Rashid et al. 1990). Medical researchers discovered that high levels of methylmercury cause severe neurological degeneration in birds, cats and humans (Minamata Disease Research Group, 1968; Harada et. al. 1995). Thus, mercury and organomercurials are ideal targets for phytoremediation.
- In water, mercury pollution also poses a problem. Mercury accumulates in the sediments of lakes and oceans where methanogenic bacteria live (http://ehpnet.niehs.nih.gov). These bacteria methylate mercury to produce methylmercury, which is eventually released into water (Harada et al. 1995). The methylmercury is trapped into the small fish when the water passes through their gills or they feed on phytoplanktons that carry high concentrations of the pollutant. Predatory fish, as bass in fresh water and tuna in salt water, live for long periods of time feeding on smaller fish. During their life span, they can accumulate high levels of methylmercury that can reach 1.0 ppm in normal water and 30 ppm in areas of high pollution with mercury (http://ehpnet.niehs.nih.gov) Then, humans and birds feed on contaminated fish and accumulation in their tissue cause severe neurological damage.
- Meagher and colleagues have used a nuclear modified form of the merA and merB genes to transform plants that are resistant to mercury and organomercurials respectively (Bizily et al. 1999; Rugh et. al. 1996), U.S. Pat. No. 5,965,796 (1999). One of the drawbacks of nuclear genetic engineering is that it requires several back crosses to create the complete pathway that detoxifies mercury and organomercurials (Bizily et al. 2000). This results in variation in expression levels among different transgenic lines and tolerance to different concentrations of organomercurials, only in low levels of tolerance (10 μM) (Bizily et al. 2000). Another concern of the use of nuclear transformed plants in-situ is the escape of the foreign genes via pollen (Daniell 1999; Bogorad, 2000).
- The present invention provides a transgenic plant bioremediation system for soil as well as a transgenic algae/bacteria bioremediation system for water.
- Non-Obviousness of Expression of Operons Via the Chloroplast Genome
- Despite the potential advantages of chloroplasts for foreign gene expression, it was not obvious that multiple genes expressed by a single promoter in chloroplasts would be expressed in this organelle in a coordinated manner. Polycistrons have been observed in chloroplasts in the past but processing RNA sequences present in between individual transcripts, proteins or enzymes involved in processing or cofactors necessary for processing of polycistrons have not yet been characterized. Therefore, it was not obvious to one skilled in the art that multiple foreign gene transcripts would be properly processed and translated when expressed from a heterologous promoter.
- Prior to this patent application there were no published reports of expression of multiple genes in chloroplasts and there were valid reasons to suggest that it would be problematic. Indeed, despite several reports of foreign gene expression via the chloroplast genome, no one ever attempted expression of a bacterial operon via the chloroplast genome because of inadequate understanding of processing of polycistrons within plastids. All foreign genes engineered via the plastid genome have been driven by individual promoters and 3′ regulatory sequences. It was not known whether 3′ terminators and regulatory sequences were necessary for individual genes of the foreign operon. It is generally believed that the proteins or enzymes involved in processing may be under the control of the nuclear genome. It was also believed that there may be several environmental factors involved in processing polycistrons, including light.
- While chloroplast ribosome binding sites have been characterized, it was not obvious that ribosome binding sites or untranslated regions upstream of bacterial genes would function in plastids. Also, it was not anticipated that a chaperonin present in a bacterial cell would function within chloroplasts and help fold the foreign protein or interfere with folding of other chloroplast proteins. It was certainly unanticipated that it was possible to create cuboidal crystals within chloroplasts duplicating the functions of a bacterium during sporulation or duplicate bioremediation pathways within plastids. There was no certainty that the enzymes of the pathway or proteins of the operon would be expressed in a coordinated manner.
- Indeed, the prior art suggested that there might have been unforeseen deleterious effects of high-level expression of several foreign proteins within chloroplasts on plant growth or development that were not apparent from the experiences with other transgenes. The pH and oxidation state of the chloroplast differs from that of bacterial cells in ways that might inhibit or prevent functions of proteins or enzymes. Because the results of this invention contradicted those teachings of the prior art, this invention was characterized as breakthrough in plant biotechnology and featured on the cover of Nature Biotechnology (the most prestigious biotechnology journal in the world) in January 2000. Scientists around the world have written reviews subsequent to that publication appreciating this invention. Engineering multiple genes in transgenic plants via the nuclear genome is not only extremely time consuming (taking several years to accomplish) but is riddled with problems of position effect, gene silencing etc. Therefore, this accomplishment was characterized as the holy-grail of plant biotechnology.
- By this invention, plastid expression constructs are provided which are useful for genetic engineering of plant cells and which provide for enhanced expression of several foreign proteins in plastids utilizing a single transformation event. The transformed plastid is preferably a metabolically active plastid, such as the chloroplasts found in green and non-green plant tissues including leaves and other parts of the plant. This invention opens the door to engineering novel pathways for metabolic engineering and gene stacking, or for multi subunit complex proteins requiring stoichiometric and coordinated expression of multiple genes. The plastid is preferably one which is maintained at a high copy number in the plant tissue of interest.
- The present invention is applicable to all plastids of plants. These include chromoplasts which are present in the fruits, vegetables and flowers; amyloplasts which are present in tubers like the potato; proplastids in roots; leucoplasts and etioplasts, both of which are present in non-green parts of plants.
- The plastid expression constructs for use in this invention generally include a single plastid promoter region and multiple genes of interest to be expressed in transformed plastids. The DNA sequence of interest may contain a number of consecutive encoding regions, to be expressed as an operon, for example where introduction of a foreign biochemical pathway into plastids is desired for metabolic engineering or gene stacking. Plastid expression constructs of this invention is linked to a construct having a DNA sequence encoding a selectable marker which can be expressed in a plant plastid.
- In a preferred embodiment, transformation vectors for transfer of the construct into a plant cell include means for inserting the expression and selection constructs into the plastid genome. This preferably comprises regions of homology to the target plastid genome which flank the constructs.
- The chloroplast vector or constructs of the invention preferably include a universal chloroplast expression vector which is capable of importing a desired trait to a target plant species. Such a vector is competent for stably transforming the chloroplast genome of different plant species which comprises an expression cassette which is described further herein. Such a vector generally includes a plastid promoter region operative in said plant cells chloroplast, a gene which is linked to a multi-gene operon which includes an ORF which codes for a putative chaperonin which facilitates the folding of the protein to form proteolytically stable cuboidal crystals. Preferably, one or more DNA sequences of interest to be expressed in the transformed plastids.
- The invention provides also a plastid vector comprising of a DNA construct. The DNA construct includes a 5′ part of a plastid DNA sequence inclusive of a spacer sequence; a promoter that is operative in the plastid; at least a heterologous DNA sequence encoding multiple peptides of interest; a gene that confers resistance to a selectable marker; a multi-gene operon; a transcription termination region functional in the target plant cells; and a 3′ part of the plastid DNA sequence inclusive of a spacer sequence. The DNA construct is flanked by DNA sequences which are homologous to the spacer sequence of the target plastid genome. The plastid is preferably a chloroplast. The vector preferably includes a ribosome binding site and a 5′ untranslated region (5′UTR). A promoter operative in the green and non-green plastids is to be used in conjunction with the 5′UTR,
- The invention provides a promoter that is operative in the green and non-green plastids of the target plant cells such as the psbA promoter, rbcL promoter, atpβ promoter region, accD promoter, and the 16SrRNA promoter.
- The invention provides a gene, which can be a mutant gene, that confers resistance, such as antibiotic resistance, to a selectable marker like the aadA gene.
- The invention provides a cassette which can be modified to include a selectable marker, a gene encoding the chaperonin and any desired heterologous gene. Such applications will be beneficial for the high level production in plants of other desired protein products as well
- Further, the invention preferably provides a three-gene insecticidal Bacillus thuringiensis (Bt) operon which shows operon expression and crystal formation via the chloroplast genome. The operon comprises of three operably linked components which operate in concert as a biosynthetic pathway: a distal gene which codes for a insecticidal protein and two open reading frames (ORF). The two ORFs code for at least one molecule of interest and at least one chaperonin to assist in the folding of the insecticidal protein. The molecule of interest of this operon can be a peptide, an enzyme, a selectable marker, or a bio-pharmaceutical, including monoclonals.
- This invention also provides for other three-gene operons, particularly insecticidal operon or the Cry2Aa2 operon. This invention also provides for operons of the Cry or Cyt series.
- An operon of this invention further provides that the second ORF (ORF2) codes for a putative chaperonin. A chaperonin is a molecule which facilitates the folding and assembly of proteins to form functional proteolytically stable cuboidal crystals. The ORF2 is operably linked to a gene encoding the insecticidal protein. The invention provides a bacterial chaperonin that is capable of facilitating the folding and assembly of insecticidal proteins.
- This invention also provides crystallized insecticidal proteins such as δ-endotoxin proteins, Cry proteins such as the Cry2Aa2 proteins, or Cyt proteins.
- In accordance of the invention, the introduction blocks of foreign genes in a single operon would avoid complications inherent in nuclear transformation such as position effect and gene silencing in putting one gene at a time into random locations in the nuclear genome. Repeated use of a single promoter causes gene silencing (De Wilte, C. et. al. 2000). Cloning several genes into a single T-DNA does not avoid the compounded variable expression problem encountered in nuclear transgenic plants. This invention shows that a bacterial operon can be expressed in a single integration event. Expression of multiple genes via a single transformation event opens the possibility of expressing foreign pathways or pharmaceutical proteins involving multiple genes.
- The invention provides for the demonstration of expression of a bacterial operon or polycistrons in transgenic plants and opens the door to engineer novel pathways in plants in a single transformation event.
- The invention provides a single vector or construct (or cassette) which encodes more than one heterologous protein product. This embodiment of the invention provides that a heterologous DNA fragment that is introduced into a universal vector encodes more than one gene. In one example shown, this invention discloses, the DNA encodes an operon of three genes and produces proteins from at least two genes, one of those genes encode a protein and a chaperone protein. This aspect of the invention—to co-expressing multiple genes—is beneficial if one skilled in the art desires to introduce a biosynthetic pathway that comprises multiple steps into plants. For example, a three step synthesis of a desired compound might require three different enzymes. A single transformation will generate a recombinant plant possessing all three heterologous enzymes which can function in concert to produce the desired product.
- Thus another embodiment of the invention relates to the maximal production of a heterologous protein by co-expressing it with another polypeptide that induces crystallization of said protein. This aspect of the invention provides the yield of heterologous gene expression is greatly enhanced if the desired protein is in crystal form in the transformed plant. The increased yield is because the crystal form of the proteins protected them from cellular proteases. This is accomplished by co-expressing the desired gene with a second gene encoding a chaperonin that directs crystallization.
- Also, formation of crystals of foreign proteins opens a simple method of purification via centrifugation. Plants transformed with the cry2Aa2 operon of the invention show a large accumulation and improved persistence of the expressed insecticidal protein(s) throughout the life of the plant. This is most likely because of the folding of the insecticidal protein into cuboidal crystals, thereby protecting it from proteases. This is an environmentally friendly approach because folded crystals improve the safety of the Bt transgenic plants. In contrast to currently marketed transgenic plants that contain soluble CRY proteins, folded protoxin crystals will be processed only by those target insects that have high alkaline gut environment. In addition, absence of insecticidal protein in transgenic pollen eliminates toxicity to non-target insects via pollen. Expression of the cry2Aa2 operon in chloroplasts provides a model system for hyper-expression of foreign proteins in a folded configuration enhancing their stability and facilitating single step purification. This is the first successful demonstration of expression of a bacterial operon in transgenic chloroplast plants.
- The invention provides a model system for large-scale production of foreign protein within chloroplasts in the folded configuration enhancing their stability and facilitating single-step purification, for example, biopharmaceuticals such as human serum albumin (HSA) and insulin.
- All known methods of transformation can be used to introduce the vectors of this invention into target plant plastids including bombardment, PEG Treatment, Agrobacterium, microinjection, etc.
- The invention provides transformed crops, like solanaceous plants (monocotyledonous and dicotyledonous). Preferably, the plants are edible for mammals, including humans.
- The invention provides target Bt transgenic plants which are likely to show a more stable protein expressed at high levels in the chloroplast throughout the growing season. It should increase toxicity of Bt transgenic plants to target insects and help eliminate the development of Bt resistance. The invention provides an example of the cry2Aa2 bacterial operon is expressed in tobacco chloroplasts to test the resultant transgenic plants for increased expression and improved persistence of the accumulated insecticidal protein(s).
- The invention provides transformed plants including leaves which accumulated a high percent of total soluble protein (close to 50%) in mature leaves and remain stable even in old bleached leaves.
- The invention provides transformed plants which are resistant to difficult-to-control insects, like cotton boll worm, which were killed 100% after consuming transgenic leaves. The invention also provides plants which contain insecticidal protein fold into cuboidal crystals. Plants which contain protoxin crystals, which will be processed only by target insects that have high alkaline gut environment, which should improve safety of Bt transgenic plants. Also, plants are free of insecticidal proteins in transgenic pollen, which eliminates toxicity to non-target insects via pollen such as Monarch butterfly larvae. The invention provides electron microscopic proof of the presence of the cuboidal crystals inside the chloroplast.
- The invention also provides an environment friendly approach to engineering insect resistance to plants because folded crystal products improve the safety of the Bt transgenic plants which will be edible consume, mammals, including humans.
- In another embodiment of the invention provides heterologous DNA sequences which mediate resistance to (a) heavy metal in transgenic plants or plant cells which express these coding sequences encoding metal ion reductases and (b) organomercurial compounds in transgenic plants or plant cells which express the coding sequence encoding organomercurylyase. Preferably the coding sequence is that of merA (which encodes mercuric ion reductase) and merB (which encodes organomercury lyase).
- The present invention provides a chloroplast universal vector which contains a Mer operon containing metal resistance coding sequences operably linked to transcriptional and translational control sequences which are functional in the chloroplast in target plants. Preferably the coding sequence is that of merA and merB. Also, the present invention provides transgenic plant cells, plant tissue and plants whose chloroplast has been modified to contain and express two metal resistance coding sequences operably linked to transcriptional and translational control sequences which are functional in the chloroplast of target plants. Preferably the coding sequences are that of merA and merB. Also provided by the present invention are methods for effecting metal resistance in plants by stably transforming a plant to contain and express two heterologous DNA sequences encoding metal resistance operably linked to transcriptional and translational control sequences which are functional in the chloroplasts of target plants. Preferably the coding sequence is that of merA and merB.
- The present invention are methods for effecting metal resistance in plants by stably transforming a green algae or cyanobacteria to contain and express two heterologous DNA sequences encoding metal resistance operably linked to transcriptional and translational control sequences which are functional in the target green algae or cyanobacteria. Preferably the coding sequence is that of merA and merB.
- A further object of the invention are transgenic plants, algae and bacteria which contain and express metal resistance and organomercurial compound resistance coding sequences.
- Other embodiments of the invention are described in greater detail hereinafter.
-
FIG. 1 shows (a) Chloroplast expression vector pLD-BD Cry2Aa2 operon (9.8 kb) with PCR primer landing sites and expected fragment sizes. PCR analysis of untransformed and putative chloroplast transformants using two primer sets: (b) 1P1M; and (c) 3P3M. Lane 1:1 kb ladder; Lane 2: untransformed; Lanes 3-7: pLD-BD Cry2Aa2 operon putative transformants; Lane 8: pLD-BD Cry2Aa2operon plasmid DNA. -
FIG. 2 shows the Southern blot analysis of T0 and T1 generations. A. The 0.81 kb probe BamH1-Bglll fragment containing the chloroplast flanking sequence. Untransformed plants generate a 4.47 kb fragment. B. Vector map showing Cry2Aa2 operon transformed 32P labeled fragments of 8.42 kb and 1.42 kb. C. Lane 1:1 kb ladder; Lane 2: untransformed; Lanes 3-7; T0 transgenic lines; Lanes 8-9: T1 transgenic lines. -
FIG. 3 shows the 10% SDS-PAGE gel stained with R-250 Coornassie Blue. Loaded protein concentrations are provided in parenthesis. Lanes 1: prestained protein standard; Lane 2: partially purified Cry2Aa2 protein from E. Coli (5 μg); Lane 3: Single Gene derived Cry2Aa2 pellet extract solubilized in 50 mM NaOH (22.4 μg); Lane 4: Single Gene derived Cry2Aa2 supernatant (66.5 μg); Lane 5: Operon Derived Cry2Aa2 supernatant (58.6 μg); Lane 7: untransformed tobacco pellet extract solubilized in 50 mM NaOH (29.8 μg); Lane 8: untransformed tobacco supernatant (30.4 μg). Colored compounds observed in the supernatant of transgenic plants interfered with the DC Bio-Rad protein assays but not in the pellet. -
FIG. 4 shows the quantification of Single Gene derived Cry2Aa2 and Operon Derived Cry2Aa2 proteins by ELISA as a percentage of total soluble protein in young, mature, and old transgenic leaves. A: Single Gene derived Cry2Aa2 expression shown as a percentage of total soluble protein. B: Operon derived Cry2Aa2 expression shown as a percentage of total soluble protein. -
FIG. 5 shows the insect bioassays of untransformed tobacco leaves (A, D, G), Single Gene derived Cry2Aa2 transformed leaves (B, E, H) and Operon Derived Cry2Aa2 transformed leaves (C, F, I). A, B, C: bioassays with H. virescens; D, E, F: bioassays with H. zea; G, H, I: bioassays with S. exigua. -
FIG. 6 shows the electron micrographs of Operon Derived Cry2Aa2 leaf sections in young (A), mature (B, D) and old, bleached leaf (C). Single Gene derived Cry2Aa2 mature leaf (E), mature untransformed leaf (F). -
FIG. 7 shows the phenotypes of untransformed (A) or transformed with the cry2Aa2 gene (B) or cry2Aa2 operon (C). -
FIG. 8 shows a pLD-merAB chloroplast vector. -
FIG. 9 shows transformed E. Coli grown in 100 μm HgCl2. Transformed E. coli cells containing the vectors pLD-merAB and pLD-MerAB-3′UTR grown in LB at different concentrations of HgCl2. Plates show transformed cells growing at 100 μM HgCl2. No growth was observed in the control. -
FIG. 10 shows chloroplast transgenic plants. A: Transgenic plant shoot induction in RMOP with 500 μg/ml Spec. B: Transgenic plant root induction in MSO with 500 μg/ml Spec. C: Transgenic plant grown in soil. -
FIG. 11 shows integration of the mer operon into the chloroplast genome. A: PCR using specific primers that land in the gene cassette (5P/2M) show a product of 3.8 kb size (clones2, 4, 5, 7, 9, 11).Clones -
FIG. 12 shows the Chlorella vulgaris vector construct. -
FIG. 13 shows the Synechocystis vector construct. -
FIG. 14 shows the Lemna vector construct. -
FIG. 15 shows the Sugarcane vector construct. -
FIG. 16 shows confirmation of Lemna vector construct. -
FIG. 17 shows confirmation of Sugarcane vector construct. -
FIG. 18 shows other vectors suitable for operon expression. - This invention is related to transformation of the plastid genome applicable to all plastids of plants. These include chromoplasts which are present in the fruits, vegetables and flowers; amyloplasts which are present in tubers like the potato; proplastids in roots; leucoplasts and etioplasts, both of which are present in non-green parts of plants
- The invention provides in one aspect a single vector or construct which encodes more than one heterologous protein product. The second aspect of the invention relates to the maximal production of a heterologous protein by co-expressing it with another polypeptide or a chaperone that induces crystallization of said protein.
- The first aspect of the invention provides that a heterologous DNA fragment that is introduced into a plastid vector (described below) encodes more than one gene. In one example, the DNA encodes an operon of three genes and produces proteins from three genes. This aspect of the invention to co-expressing multiple genes is beneficial if one desires to introduce a biosynthetic pathway into plants that comprises multiple steps. For example, a three step synthesis of a desired compound might require three different enzymes. Co-expressing all three enzymes in the chloroplast can be accomplished according to this invention. Thus, a single transformation will generate a recombinant plant possessing all three heterologous enzymes which can function in concert to produce the desired product.
- The second aspect of the invention is that the yield of heterologous gene expression is greatly enhanced if the desired protein is in crystal form in the transformed plant, as provided by this invention. This is accomplished by co-expressing the desired gene with a second gene encoding a chaperone protein that directs crystallization. Data given in the specification shows almost 100 fold greater amounts of insecticidal protein can be found in plants co-expressing the chaperone protein versus plants having only the gene encoding the insecticidal protein. The expression cassette itself can be modified to include a selectable marker, a gene encoding the chaperone protein and any desired heterologous gene. Such applications will be beneficial for the high level production in plants of other desired protein products as well.
- A further aspect of the invention describes a plant bioremediation system. A plant bioremediation system employing chloroplast transformants have a number of advantages. First, plants have the genetic capacity (using hundreds, even thousands, of genes) to extract at least 16 metal cation and oxyanion nutrients from the soil and ground water. This capacity can be chemically and genetically manipulated to extract environmental pollutants. Second, plants have extensive root systems to help in this mining effort; typical estimates are as high as 100×106 miles of roots per acre [Dittmer, H. J. (1937) Amer. J. Botany 24:417-420]. The root systems of various macrophytes can reach up to 40 feet into the soil. In addition, plants are photosynthetic and govern as much as 80% of the available energy at any given time in most ecosystems. Through photosystem I (a system not found in photosynthetic bacteria), they use light energy to generate large amounts of reducing power (as NADPH) that can be used to efficiently reduce metal ions. Plants photosynthetically fix CO2 and reduce it to make their own carbon/energy source. This reduced carbon energy is used by plant roots to live heterotrophically. This redox power can also be used to reduce toxic metal ions like Hg(II) [Rugh et al. (1996) supra]. Many plants can produce large amounts of biomass annually with the potential both to enrich contaminated soil with carbon and nutrients and/or remove metal ions from the soil. The site of action of mercury within the chloroplasts, ability to express bacterial operon via the chloroplast genome, and several other environmental benefits of chloroplast genetic engineering make this an advantageous system for metal remediation.
- An additional benefit of the metal resistant plants is their ability to harvest metals; precious and semi-precious metals can be reduced and thereby trapped in plant tissues. These metals include can include gold, silver, platinum, rhenium, copper, palladium, nickel, zinc and cadmium, where the corresponding metal ions are reduced by the metal resistance gene product in those plants.
- In addition, this invention also introduces a novel approach for mercury and organomercurial bioremediation in water. Two organisms are used as model systems. One is Synechocystis, a photosynthetic bacterium (Cyanobacterium) that grows in salt and fresh water (in a high temperature range, from ice to hot springs). The other is Chlorella vulgaris, a green algae that grows in fresh water. These organisms are transformed with the merA and merB genes (mer operon) to remove mercury and organomercurials from water. Transformed cells could be applied for sludge treatment and in water treatment to remove organomercury and mercury form water and sediments before releasing them to the environment, especially from industrial effluents that generate byproducts with mercury.
- “Metal resistance” means that anon-naturally occurring organism is not inhibited by the presence of at least one of divalent cations of mercury, cadmium, cobalt, trivalent cations of gold, and monovalent silver ion, at concentrations (levels) at which a naturally occurring (wild-type) counterpart of the non-naturally occurring organism is inhibited or exhibits symptoms of toxicity. It is not intended that the term metal resistance refer to resistance to unlimited concentration of metal ions, but rather the term is relative in that it relies on comparison to the properties of a parental strain.
- A “metal resistance coding sequence” is one which encodes a protein capable of mediating resistance to at least one metal ion, including, but not limited to, divalent cations of mercury, nickel, cobalt, trivalent cations of gold, and by monovalent cations of silver. Also within the scope of this definition are mutant sequences which determine proteins capable of mediating resistance to divalent cations of lead, cadmium and copper.
- An “organomercurial resistance coding sequence” is one whose protein product mediates resistance to such organic mercury compounds as alkylmercurials and certain aromatic mercurials, for example, mono- or dimethyl mercury, typically in conjunction with a metal resistance gene such as merA. As specifically exemplified herein, the organomercurial resistance gene is the methylmercury lyase gene (merB) and its gene product confers resistance to organomercurial compounds such as methymercury, p-chloromercuribenzoate (PCMB) and p-hydroxymercuribenzoate in conjunction with the merA gene product (mercury ion reductase).
- The metal resistance protein (MerA protein, mercuric ion reductase) is exemplified by that from Tn21, a bacterial mercury resistance transposon originally isolated from the IncFII plasmid NR1. In addition to reducing mercuric ions, the Tn21 MerA reduces trivalent gold and monovalent silver cations [Summers and Sugarman (1974) Journal of Bacteriology 119:242-249]. Monovalent silver and certain divalent metal cations have been shown to be competitive inhibitors of mercuric ion reduction in vitro [Rinderle et al. (1983) Biochemistry 22:869-876]. MerA mediates resistance to trivalent gold, divalent cobalt, divalent copper and divalent nickel cations as well as divalent ionic mercury.
- It is understood that nucleic acid sequences from nucleotide 14 through nucleotide 1708, or
MerApe 20, MerApe 29, MerApe 38 or MerApe 47 will function as coding sequences synonymous with the exemplified merApe9 coding sequence. Nucleic acid sequences are synonymous if the amino acid sequences encoded by those nucleic acid sequences are the same. The degeneracy of the genetic code is well known to the art; i.e., for many amino acids, there is more than one nucleotide triplet which serves as the codon for the amino acid; for expression in plant cells or tissue it is desired that codon usage reflect that of plant genes and that CpG dinucleotides be kept low in frequency in the coding sequence. It is also well known in the biological arts that certain amino acid substitutions can be made in protein sequences without affecting the function of the protein. Generally, conservative amino acid substitutions or substitutions of similar amino acids are tolerated without affecting protein function. Similar amino acids can be those that are similar in size and/or charge properties, for example, aspartate and glutamate and isoleucine and valine are both pairs of similar amino acids. Similarity between amino acid pairs has been assessed in the art in a number of ways. For example, Dayhoff et al. (1978) in Atlas of Protein Sequence and Structure, Vol. 5, Suppl. 3, pp. 345-352, which is incorporated by reference herein, provides frequency tables for amino acid substitutions which can be employed as a measure of amino acid similarity. Dayhoff et al.'s frequency tables are based on comparisons of amino acid sequences for proteins having the same function from a variety of evolutionarily different sources. - The expression of merB in plants confers resistance to and/or the ability to detoxify organomercurials including, but not limited to, alkylmercury compounds wherein the alkyl group is either straight chain or branched, alkenyl mercury compounds, allyl mercury, alkynyl mercury compounds, aromatic mercury compounds, wherein there are from one to about 6 aromatic rings, and other organomercurials including but not limited to humic acid-containing mercury compounds. The MerB protein also mediates resistance to and/or detoxifies organo-metals including, but not limited to, organic lead, organic cadmium and organic arsenic compounds, where those organometals can be alkyl, aklenyl, alkynyl or aromatic metal compounds.
- Coding sequences suitable for expression in a plant are operably linked downstream of a constitutive or a regulated promoter construct. Transgenic plants can be constructed by use of chloroplast universal vector containing a 5′ a part of a chloroplast spacer sequence, a promoter that is operative in the chloroplast of the target plant cells, at least two heterologous DNA sequences encoding merA and merB, a gene that confers resistance to a selectable marker; a transcription termination region functional in the target plant cells; and a 3′ part of the chloroplast spacer sequence. Alternatively, the vector may not contain a terminator.
- The mer operon-expressing plants can be used in the remediation of mercury-contaminated soil to block the biomagnification of methyl mercury up the food chain. Deep-rooted trees like cottonwood and sweetgum, which inhabit bottom lands, can be transformed to express mer A and merB. These species have roots that grow in the same general area of the sediment as sulfate-reducing bacteria. As the transgenic plant roots take up methyl mercury, MerB breaks the carbon mercury bond to produce Hg(II). Hg(II) is a highly reactive metal ion and should end up sequestered in plant tissues bound to various thiol groups.
- Hg(II) produced from the MerB reaction and additional Hg(II) taken up from the environment through its normal mining of nutrients is reduced to Hg(0) by the MerA reaction. Hg(0) is released directly from the roots or transpired up the vascular system of the plant, as are waste gasses like CO2 from some plants [Dacey, J. W. (1980) Science 210: 1017-1019; Dacey, J. W. (1981) Ecology 62:1137; Raven et al. (1986) In: Biology of Plants, Worth Publishers, N.Y., p. 775]. By lowering the total levels in the soil, less methyl mercury will be produced by sulfate-reducing bacteria. Using the MerA and MerB together in transgenic plants at contaminated sites lowers total Hg(II) levels and destroys environmental methyl mercury, thus preventing a large portion of the methyl mercury from moving through the environment.
- The Hg(0) entering the environment joins the enormous and stable pool of Hg(0) in the atmosphere (Nriagu (1979) In: The Biogeochemistry of Mercury in the Environment, (New York: Elsevier) with half life of over one year. Because Hg(0) is not easily returned to earth, this pool is not thought to contribute less significantly to manmade contamination of the environment. In contrast, atmospheric Hg(II) species (i.e., mercury released from coal burning or methyl mercury released naturally) are rapidly returned to earth by rain and dry deposition with a half-life of about 1-2 weeks. Thus, volatilization of relatively small amounts of Hg(0) with good air circulation effectively removes mercury from terrestrial and aquatic environments.
- Once a transgenic plant population expressing MerA and MerB is established, these plants efficiently process mercury. Over the subsequent few decades these plants remove or detoxify most mercury from at a site. Relying only on currently available biological and chemical processing, the efflux rates of Hg(0) from mercury contaminated sites are extremely slow. At one such government site it is estimated that only 10 kg of the 80,000 kg present in the soil is released as Hg(0) per year (Lindberg et al. (1995) Environ. Sci. Tech. 29, 126-135). The levels of atmospheric mercury at this and most sites (4-10 ug/m.sup.3) are 10,000 fold below what the EPA/OSHA recommend as the maximum allowable levels (U.S. Public Health Service (1994) Toxicological Profile for Mercury. In: Regulations and Advisories, U.S. Public Health Service, Washington, D.C., pp. 261-269). Even if transgenic plants at this site increased the efflux rate of metallic mercury 200 times, the level of atmospheric mercury would still be 50 fold below these allowable levels. The transgenic plants of the present invention allow the efficient removal of toxic metal compounds such as methyl mercury and ionic mercury from soil, sediment, and aquatic environments, thus meeting a longfelt need for efficient bioremediation of metal and organometal contaminated sites.
- The cry2Aa2 Operon. The preferred embodiment of the invention is the use of Bacillus thuringiensis (Bt) cry2Aa2 operon as a model system to demonstrate operon expression and crystal formation via the chloroplast genome of tobacco. This operon contains three open reading frames (ORFs). Cry2Aa2 is the distal gene of this operon. The ORF immediately upstream of cry2Aa2 codes for a putative chaperonin that facilitates the folding of cry2Aa2 (and other selected target proteins) to form proteolytically stable cuboidal crystals. Because CRY protein levels decrease in plant tissues late in the growing season or under physiological stress, a more stable protein expressed at high levels in the chloroplast throughout the growing season should increase toxicity of Bt transgenic plants to target insects and help eliminate the development of Bt resistance. The function of the third ORF is not yet known. The invention comprises the operon with the third gene and also with the operon without the third gene.
The mer Operon. Another embodiment of the invention uses the mer Operon. The genes for mercury resistance are known as Mer genes, they are found in operons of bacterial pasmids; different genes constitute operons, but the two most important are: the merA that codes for the mercuric ion reductase and the merB that codes for the organomercurial lyases (Foster, 1983; Summers et al. 1978, 1986). Mer A is a 1.7 kb gene that needs NADPH as a co-factor to reduce mercury to a volatile, non-reactive and less toxic form of mercury (Hg0) (Begley et al. 1986). Mer B is a 638 bp gene that undergoes the protonolysis of organomercurials by removing the organic group and releasing elemental mercury, which is detoxified by merA (Jackson et al. 1982). A polycistron containing both genes allows effective degradation of mercury and organornercurials - Alternative Operons
- Other Cry or Cyt operons may be used in this invention. Any operon which comprises at least one of the 133 genes shown in the article MMBR, September 1998, pages 805-873, Vol 62, No. 4, Revision of the Nomenclature for the BT Insecticidal Crystal Proteins by Crickmon et al., the genes of which codes for the corresponding BT protein; and the chaperonin which facilitates protein folding can be used. Likewise, any operon which comprises at least one of the toxins enumerated in Table 15.1 or at least one of the of Molecular Biotechnology by Glick and Pasternak can be used. Similarly, any operon which comprises a gene which codes for a delta-endotoxin and the chaperonin which facilitates protein folding can be used. In addition, any operon which comprises at least a plasmid identified in Table 13.1 of the of Molecular Biotechnology by Glick and Pasternak can be used.
- The Chaperonins
- Chaperonins are a class of a protein referred to as chaperones which has been shown to consist of helper proteins in chain folding and assembly with the cells (Gierasch and King, 1990). They facilitate the folding and assembly of newly synthesized polypeptide chains into functional three-dimensional structures by preventing off-pathway reactions during folding that lead to aggregation (Agashe V R et. al. 2000). Chaperonins provide a sequestered environment in which folding can proceed unimpaired by intermolecular interactions between non-native polypeptides (Agashe V R et. al. 2000). Those skilled in the art will be familiar with the E. Coli chaperonins: groEL and groES (Viitanen P V et. al. 1995), (Gierasch and King, 1990). Plant chaperonins chaperonin-60 and chaperonin-10, which are homologous of gro-EL and gro-ES, respectively. Homologous of the E. Coli groEL and groES continue to be identified. For instance, a stable complex of the chaperonins has been isolated and crystallized from the extremely thermophilic bacterium Thermus thermophilus (Lissin N M et. al. 1992). Likewise, plant chaperonins—located both in plastids and the cytosol, continue to be identified (Baneyx F. et. al., 1995; Viitanen P V et. al., 1995; Burt W J et. al. 1994, Grellet F. et. al. 1993; Bertsch U et. al., 1992). These articles are hereby incorporated in their entirety by reference.
- The preferred embodiment of this invention use of those bacterial chaperonins that are capable of facilitating the crystallization of the Bt endotoxin polypeptides by means of the UV Ct vector and in the transformed plants.
- The Vectors
- This invention contemplates the use of vectors which are capable of stably transforming the chloroplast genome. Such vectors include chloroplast expression vectors such as pUC, pBlueScript, pGEM, and all others identified by Daniell in U.S. Pat. Nos. 5,693,507 and 5,932,479. These publications and patents are herein incorporated by reference to the same extent as if each individual publication or patent was specifically and individually indicated to be incorporated by reference.
- Universal Vector. A preferred embodiment of this invention utilizes a universal integration and expression vector competent for stably transforming the chloroplast genome of different plant species (Universal Vector). The universal vector and its construction have been described by the earlier Publication No. WO99/10513, International publication date: 4 Mar. 1990, which is herein incorporated in its entirety.
- The 4.0 kb cry2Aa2 operon was inserted into the universal chloroplast expression vector pLD CtV2 (5.8 kb) to form the final E. coli and tobacco shuttle vector pLD-BD Cry2Aa2 operon (9.8 kb) (
FIG. 1A ). This vector could be used to transform chloroplast genomes of several plant species because the flanking sequences are highly conserved among higher plants. This vector contains the 16S rRNA promoter (Prrn) driving the aadA gene (aminoglycoside 3′-adenylyltransferase) for spectinomycin selection and the three genes of the cry2Aa2 operon. The terminator is thepsbA 3′ region from the tobacco chloroplast genome from a gene coding for the photosystem II reaction center component. The 16S rRNA promoter is one of the strong chloroplast promoters recognized by both nuclear and plastid encoded RNA polymerases in tobacco and thepsbA 3′ region stabilizes the transcript of foreign genes. This construct integrates both genes into the spacer region between the chloroplast transfer RNA genes coding for isoleucine and alanine within the inverted repeat (IR) region of the chloroplast genome by homologous recombination. The integration into these transcribed spacer regions allow the gene to be inserted without interfering with gene coding regions. Also, each genome will contain two gene copies due to integration into the two inverted repeat regions resulting in a higher copy number (7,000-8,000 copies per cell) and higher levels of expression. However, the two genes may also be integrated outside of the IR region resulting in a lower copy number. Chloroplast transgenic plants were obtained as described previously by Daniell (1993, 1997). - Mer operon vectors with and without terminator: In order to understand the role of 3′UTRs in chloroplast foreign gene expression (in mRNA stability and transcription termination), chloroplast vectors with and without 3′ UTRs were made. The PCR products, merA and merB were cloned independently into the pCR2.1 vector (In Vitrogen). Then, the orientation of the merB gene integration was checked. Once the correct orientation was found, the vector TA-merB was cut with a ClaI/EcoRV. MerA was cut with ClaI and EcoRV, and the fragment (merA) was isolated by gel electrophoresis. Then, the merB and merA genes were ligated. After the ligation, both genes (merB and merA) in-frame were ready for insertion into the pLD vector. After cutting pLD vector with PstI to linearize the vector and to remove the terminator, the merB-merA cassette extracted from the TA-vector was ligated into the pLD vector (
FIG. 8 ). The final step was to check for correct orientation. Thus the pLD-merAB vector lacking 3′ UTR was constructed. - To make the pLD-merA.B-3′UTR, specific set of primers were used to amplify the whole cassette from the TA-merAB vector. The 5′ primer was designed with an EcoRV site and the 3′ primer with a XbaI site. These restriction sites allowed the integration into the pLD vector only in the right orientation.
- Chloroplast Integration of Foreign Genes
- Foreign gene integration into the chloroplast genome was determined by PCR screening of chloroplast transformants (
FIGS. 1 A,B,C). Primers were designed to eliminate spectinomycin mutants and nuclear integration. The first primer set, 1P1M, lands one primer (1P) on the 3′ end of the 16s rRNA flanking sequence and another primer (1M) on aadA (FIG. 1A ). This is to distinguish between spectinomycin mutants and true spectinomycin transformants. A 1.6 kb fragment is seen in true transformants (FIG. 1B ,lanes Lane 4 shows a spectinomycin mutant with no PCR product. Untransformed tobacco DNA (lane 2) expectedly shows no product, while pLD-BD cry2Aa2 operon plasmid DNA inlane 8 produced the 1.6 kb fragment. The second primer set, 3P3M, lands one primer (3P) on the native chloroplast genome adjacent to the point of integration, and another primer (3M) on the aadA gene (FIG. 1A ). This primer set generated a 1.65 kb PCR product in chloroplast transformants (FIG. 1C ,lanes lane 8 also showed no PCR product because 3P lands on native chloroplast DNA.Lane 4 was negative for chloroplast integration and again proving this transformant to be a spectinomycin mutant. - Southern blot analysis was done to further demonstrate site-specific chloroplast integration of the 4.0 kb cry2Aa2 operon and to determine heteroplasmy or homoplasmy (
FIG. 2 ). Bglll digested DNA from transformed plants produce 8.42 kb and 1.4 kb fragments (FIG. 2B ) when probed with the 0.81 kb probe (FIG. 2A ) that hybridizes to the trn1 and trnA flanking sequences. Transgenic plant DNA (T0 and T1) produced the 8.42 kb and 1.4 kb fragments (FIG. 2C , lanes 3-9). A 4.47 kb fragment (FIG. 2A ) is seen in untransformed plant DNA (FIG. 2C lane 2). T0 plant DNA also shows this native untransformed 4.47 kb fragment (FIG. 2C , lanes 3-7), thereby showing heteroplasmy in the T0 generation. This 4.47 kb native band is absent from the T1 generation (FIG. 2C , lanes 8-9), thus indicating homoplasmy. If only a fraction of the genomes were transformed, the gene copy number should be less than 8,000 per cell. Confirmation of homoplasmy in T1 transgenic lines indicates that the Cry2Aa2 operon gene copy number could be as many as 7000-8,000 per cell. - CRY2Aa2 protein expression and quantification: Expression profile of the operon derived (OD) Cry2Aa2 and single gene derived (SG) Cry2Aa21 is shown on a Coomassie stained SDS-PAGE gel (
FIG. 3 ). The primary goal of this experiment is to investigate the location of the operon derived Cry2Aa2 protein (the pellet or supernatant) and correlate with cuboidal crystals observed in electron micrographs (seeFIG. 6 ).Lane 2 contains partially purified 65 KD Cry2Aa2 from E. coli. Because crystalline Cry2Aa2 inclusion bodies are solubilized at high alkaline pH, the 50 mM NaOH solubilized pellet was analyzed from each plant sample after centrifugation for 20 min at 13,000 g (lanes lanes 7, 8). - Cry 2Aa2 polypeptides (
FIG. 3 ,lanes 3, 5) were scanned using Storm 840 Gel Scanner and Image Quant Software (Molecular Dynamics). The operon-derived expression results only in a 2.5 fold more accumulation of Cry2Aa2 than that of single gene derived cry2Aa2 in the pellet fraction; this does not correlate with more than 100 fold difference observed in ELISA (FIG. 4 ). The reason for this discrepancy is the extreme difference in solubilization between SG Cry2Aa2 derived amorphous inclusion bodies and the OD Cry2Aa2 derived cuboidal crystals, as reported previously. - Despite the large difference in protein accumulation (as shown by ELISA and electron micrographs,
FIGS. 4 , 6), the concentration of solubilized protein loaded in the pellet fraction was similar in SG Cry2Aa2 and OD Cry2Aa2 (FIG. 3 ,lanes 3, 5). Attempts to completely solubilize crystalline inclusion bodies for SDS PAGE analysis were not successful because higher pH interfered with gel electrophoresis and repeated dilution decreased protein concentration below detectable levels in Coornassie stained gels. - However, for quantification using ELISA it was possible to completely solubilize crystalline inclusion bodies under optimal conditions and dilute the protein to fit within the linear range of the Cry2aA2 standard. Therefore, protein expression levels of SG Cry2Aa2 and OD Cry2Aa2 were quantified using ELISA (
FIG. 4 ). Additionally, CRY protein accumulation in young, mature, and old transgenic leaves derived from a single gene or operon was compared to investigate their stability over time. Young, mature, and old leaves expressed SG Cry2Aa2 at 0.014%, 0.36%, and 0.03% respectively (FIG. 4A ). Cry2Aa2 levels peaked in the mature leaf (0.36%) and drastically declined to 0.03% as the plant senesced. However, young, mature, and old leaves containing OD Cry2Aa2 accumulated at 34.9%, 45.3%, and 46.1% respectively (FIG. 413 ). As these transgenic plants aged, OD Cry2Aa2 concentrations remained stable and did not decline like the SG Cry2Aa2. The presence of the operon-expressed putative chaperonin should enable the toxin to be folded into stable crystalline structures that are protected from degradation. Based on quantitative expression, the cry2Aa2 operon derived expression levels are comparable to that of the RuBis Co, the most abundant protein on earth that compromises up to 65% of leaf soluble protein. - Insect Bioassays Five-day-old tobacco budworm (Heliothis virescens), ten day old cotton bollworm (Helicoverpa zea) and beet armyworm (Spodoptera exigua) larvae consumed the entire leaf after 24 hrs on the untransformed control (
FIGS. 5A , D, G). H. virescens feeding on SG Cry2Aa2 leaves died after 5 days (FIG. 5B ) while insects died after 3 days on OD Cry2Aa2 leaves (FIG. 5C ). For SG Cry2Aa2, H. zea consumed considerable leaf material after 24 hr, stopped feeding after three days and died after five days (FIG. 5E ). H. zea consumed very little OD Cry2Aa2 material after 24 hours, stopped feeding, and died after five days (FIG. 5F ). S. exigua feeding on SG Cry2Aa2 (FIG. 5H ) or OD Cry2Aa2 (FIG. 51 ) were lethargic after 24 hours and died after 48 hours. Milkweed leaves dusted with OD Cry2A2 transgenic pollen were not toxic to Monarch butterfly larvae (data not shown) confirming earlier observations that foreign proteins are not present in tobacco pollen.
Electron Microscopic Analysis: Untransformed and transgenic leaf sections were immunogold-labeled with a Cry2A polyclonal antibody (FIG. 6 ). Figures A-C show developmental OD Cry2Aa2 in chloroplasts in young, mature, and old leaves, respectively. In a young green OD Cry2Aa2 transgenic leaf (FIG. 6A ), labeled Cry2Aa2 occupies a significant amount of the chloroplast, but no crystalline structures are observed. In a mature green OD Cry2Aa2 transgenic leaf (FIG. 6B ), labeled Cry2Aa2 occupies a larger amount of the chloroplast than the younger leaf, resulting in crystals. Theses cuboidal crystals are essentially identical to those expressed in wild-type Cry2Aa2 crystals, or recombinantly in Bt or E coli. In an old bleached OD Cry2Aa2 transgenic leaf (FIG. 6C ), labeled Cry2Aa2 maintains the crystalline structure and occupies the highest volume of the chloroplast observed, despite being bleached and senescent. These findings correlate with OD Cry2Aa2 ELISA results. In young developing leaves, OD Cry2Aa2 begins accumulation (34.9%), folds Cry2Aa2 into a cuboidal configuration in mature leaves occupying more cell volume (45.3%), and maintains this cuboidal structure and volume in old leaves (46.1%). Essentially, as the transgenic OD Cry2Aa2 plant ages, OD Cry2Aa2 is accumulated, folded and maintained. -
FIG. 6D is a mature green OD Cry2Aa2 transgenic leaf showing crystal formation with no immunogold label. This probably occurs because as the Cry2Aa2 is folded by the putative chaperonin, epitopes are concealed thereby decreasing labeling. Crystal formation inFIG. 6D would cause the OD Cry2Aa2 to pellet after centrifugation as seen in SDS-PAGEFIG. 3 (lane 5). In EM analysis of mature leaves expressing SG Cry2Aa2 (FIG. 6E ), protein aggregation is observed, although no crystalline folding is seen. Cry2Aa2 immunogold labeling occurs in an area of much lower density than is seen in OD Cry2Aa2 transgenic plants suggesting lower expression. These results also correlate with ELISA (0.36% in SG Cry2Aa2 in mature leaves). There is no localized antibody observed in untransformed tobacco (FIG. 6F ). - Transgenic phenotypes: Phenotypes of OD Cry2Aa2 transgenic plants are not morphologically different from SG Cry2Aa2 transgenic plants (
FIG. 7 ). Therefore, higher levels of expression and accumulation of CRY proteins did not visibly impact their phenotype. Both transgenic plants flowered and set seeds. Characterization of OD Cry2Aa2 T. transgenic plants for stable integration and transmission of foreign genes has been shown earlier (FIG. 2 ). - This invention enables expression of polycistrons in the chloroplast genome. In contrast to prior efforts in engineering gene expression in transgenic plants, the present invention allows for this achievement in a single transformation event that is environmentally safe. The invention thus opens the possibility for gene pyramiding: the insertion of multiple insecticidal genes. The invention contemplates operons which include not only Bacillus thuringiensis (B.t.) insecticidal toxin genes, but also non-B.t. insecticidal toxin genes such as cholesteral oxidase, alpha-amylase inhibitors, protease inhibitors, the cowpea trypsin inhibitors, and the potato proteinase inhibitor II. Inclusion of multiple heterologous insecticidal toxin genes retards the ability of insects to develop resistance to bio-pesticides.
- Further, this invention provides a method of engineering biological pathways into the chloroplast genome in a single transformation event that is environmentally safe. Because gene expression is controlled by one promoter, DNA sequences encoding the different genes necessary in a pathway can be co-expressed to the same levels. Once expressed, the genes of the pathway can act in concert. Gene expression can result in synthesis of enzymes that confer desired traits such as degradation of metal ions, herbicides, pesticides, solvents, toulene, napthalene, and other xenobiotics. An example is the chloroplast transformation of plant chloroplasts with the Mer operon leading to the biodegradation of mercury and organomercurials. Other pathways include the pigment biosynthesis pathway, biosynthetic pathways for enzymes that are could confer desired traits such as degradation of xenobiotic compounds noted above, pathways for amino acids such as the lysine biosynthetic pathway, and pathways for the synthesis of vitamins, carbohydrates, fatty acids, biopolymers and polyesters. Further examples are provided in
chapters 12 and 13 of Molecular Biotechnology by Glick and Pasternak, which is herein incorporated by reference. Other xenobiotics which can be degraded using the system of this invention include those given in U.S. Pat. No. 4,259,444 to Chakrabarty which is herein incorporated by reference. - Expression of pathways can result in the production of compounds such as amino acids, fatty acids, carbohydrates, polymers, vitamins, antibiotics and dyes.
- The ability to express polycistrons also opens up the possibility of efficiently expressing bio-pharmaceuticals such as monoclonal antibodies. Those skilled in the art will know the four DNA sequences encoding proteins necessary to compose the molecule. Those skilled in the art will also know that these proteins should be produced in equal amounts (the same stoichiometric ratio). The PCT application entitled “Production of Antibodies in Transgenic Plastids,” filed on Feb. 28, 2001 by Daniell, is hereby incorporated by reference to offer examples of such proteins. This invention allows for the coordinated expression of these sequences because they are driven by the same promoter. This method avoids the problems of the prior art; namely the pitfalls of nuclear transformation such as the positional effect and gene silencing.
- This invention provides any higher plants, such as monocotyledonous and dicotyledonous plant species. The plants that may be transformed via the universal vector with an antibiotic selectable marker may be solanacious plants or plants that grow underground. Most importantly, this invention is applicable to the major economically important crops such as maize, rice, soybean, wheat, and cotton. A non-exclusive list of examples of higher plants which may be so transformed include cereals such as barley, corn, oat, rice, and wheat; melons such as cucumber, muskmelon, and watermelon; legumes such as bean, cowpea, pea, peanut; oil crops such as canola and soybean; solanaceous plants such as tobacco; tuber crops such as potato and sweet potato; and vegetables like tomato, pepper and radish; fruits such as pear, grape, peach, plum, banana, apple and strawberry; fiber crops like the Gossypium genus such as cotton, flax and hemp; and other plants such as beet, cotton, coffee, radish, commercial flowing plants, such as carnation and roses; grasses, such as sugar cane or turfgrass; evergreen trees such as fir, spruce, and pine, and deciduous trees, such as maple and oak.
- The invention now being generally described, it will be more readily understood by reference to the following examples which are included for purposes of illustration only and are not intended to limit the present invention.
- In the experimental disclosure which follows, all temperatures are given in degrees centigrade (.degree), weight are given in grams (g), milligram (mg) or micrograms (.mu.g), concentrations are given as molar (M), millimolar (mM) or micromolar (.mu.M) and all volumes are given in liters (l), milliliters (ml) or microliters (.mu.l), unless otherwise indicated.
- The invention is exemplified in the following non-limiting examples which are only for illustrative purposes and are not intended to limit the scope of the invention.
- Bombardment and selection of transgenic plants: Tobacco plants were grown aseptically under fluorescent lights in the laboratory. Seeds were germinated on MSO medium at 27° C. with photoperiods of 16 hour light and 8 hour dark. Microcarriers coated with pLD-BD Cry2Aa2 operon DNA was used to bombard sterile leaves using the Bio-Rad PDS-1000/He biolistic device as described by Daniell (1997). Bombarded leaves were subjected to two rounds of selection on RMOP medium containing 500 μg/ml of spectinomycin to regenerate transformants.
- PCR Analysis: DNA was extracted from leaves using the QIAGEN DNeasy Plant Mini Kit. PCR was done using the Perkin Elmer Gene Amp PCR System 2400. All PCR reactions were performed using the Qiagen Taq DNA Polymerase Kit. Primer sequences used were: 1P (5′-ACAATGTAGCCGTACTGGA AGGTGCG GGTG-3′), 1M (5′-CGCGCTT AGC TGGATAACGCCACGGAA-3′), 3P (5′-AAAA CCCGTCCTCA GTTCGGATTGC-3′), and 3M (5′-CCGCGTTGTTTCATCAA GCCTTACG-3′). Samples were run for 30 cycles with the following sequence: 94° C. for 1 minute, 70° C. for 1.5 minutes, and 72° C. for 3 minutes. PCR products were separated on 0.8% agarose gels.
- Southern Blot Analysis: DNA from transformed and untransformed plants was digested with BgIII and transferred to a nylon membrane by capillary action. The 0.81 kb probe was generated by digesting pLD-CtV2 vector DNA with BamH1/BgIII and labeled with 32P using the ProbeQuant™ G-50 Micro Columns (Amersham). Labeled probe was hybridized with the nylon membrane using the Stratagene QUICK-HYB hybridization solution and protocol.
- SDS-PAGE Analysis: Transgenic and untransformed leaf material (600 mg) was ground to a powder in liquid nitrogen. Protein extraction buffer from the Cry2Aa2 plate kit from Envirologix (Portland, Me.) used for quantification was added to the powder and further grinding was performed. The mixture was centrifuged at 4° C. at 13,000 g for 20 minutes. The supernatant was removed, boiled in sample buffer, and loaded on a 10% SDS-PAGE gel. The pellet was resuspended in 50 mM NaOH and centrifuged at 4° C. at 5000 g for 5 minutes to pellet cell debris. The supernatant was removed, boiled in sample buffer, and loaded on a 10% SDS-PAGE gel at 200V for 4 hours. Gels were stained for 2 hours with R-250 Coomassie Blue and destained overnight in 40% methanol and 10% acetic acid. The DC protein assay by Bio-Rad was used to determine total soluble and pellet protein concentration as followed by protocol.
- ELISA: A Cry2Aa2 plate kit from Envirologix was used. Leaves expressing the SG Cry2Aa2, the OD Cry2Aa2, and untransformed tobacco were quantified and compared. Approximately 20 mg of leaf was ground in 100 μl of 50 mM NaOH to solubilize CRY proteins. Transgenic leaf extracts were diluted to fit in the linear range of the provided Cry2aA2 standard. The μQuant microtiter plate reader from Bio-Tek read the plate at 450 nanometers (nm). A 1 ppm Cry2Aa2 standard was supplied by the kit and was used in the linear range between 200-1000 ng for quantification. Color development is proportional to Cry2Aa2 concentration in the sample extract. The DC protein assay by Bio-Rad was used to determine total soluble protein concentration as followed by protocol.
- Insect Bioassays Leaf disc bioassays were conducted on ca. 2 cm2 excised leaf material, and placed on distilled water-soaked cardboard lids in 50×12 mm plastic petri dishes. Insects used were susceptible H. virescens (YDK) obtained from Fred Gould, North Carolina State University, H. zea obtained from the USDA AIRS facility in Tifton, Ga. and S. exigua from the lab of William Moar. Insects were tested as five day or ten day old. All larvae were reared on typical lepidopteran artificial diet prior to use. Two insects were assayed per leaf sample, except H. zea in which only 1 insect was added per leaf sample due to the cannibalistic nature of the insect (2 leaf samples for H. zea). All leaf samples for each replicate were from the same leaf. Two samples were evaluated per treatment, and observed daily for mortality and leaf damage for 5 days. Treatments were replicated three times.
- Transmission Electron Microscopy and Immunogold Labeling: Immunogold labeled electron microscopy was performed as described by A. J. Vrekleij et. al. Sections were first incubated with 0.05M glycine in PBS buffer (10 mM phosphate buffer, 150 mM NaCl pH 7.4) for 15 minutes to inactivate residual aldehyde groups. The grids were then blocked by placing them onto drops of PBS with 5% BSA and 0.1% CWFS gelatin supplemented with 5% normal serum for 30 minutes, washed on drops of
incubation buffer 3 times for 5 min each, and then incubated for 45 min with the polyclonal Cry2Aa2 to detect tobacco expression (diluted 1:10,000 in incubation buffer). To remove unbound primary antibody, sections were washed on drops ofincubation buffer 6×5 min each. Sections were then incubated for 2 hours with a goat anti-rabbit IgG secondary antibody conjugate to 10 nm gold diluted 1:100 in incubation buffer. Sections were subsequently washed 6×5 minutes in incubation buffer, 3×5 min with PBS, and post-fixed in 2% glutaraldehyde diluted in PBS for 5 min. Following post-fixation, sections were washed inPBS 3×5 minutes, in distilledwater 5×2 min each, and post-stained using uranylacetate and lead citrate. Sections were then examined in aZeiss EM 10 transmission electron microscope at 60 kv. - E. Coli Transformants. Due to the similarity of protein synthetic machinery (Brixey et al. 1997), expression of all metal resistance conferring chloroplast vectors are first tested in E. coli before their use in tobacco transformation. The activity of the enzymes, mercury ion reductase (merA) and organomercurial lyase (merB) are tested by transforming E. coli (XLI-blue) with the recombinant plasmids and growing them in LB solid medium with HgCl2 (
FIG. 9 ). The cells, control (XLI-blue), pLD-merAB and pLDmerAB-3′UTR are grown in different concentrations of Hg Cl2. Control cells do not grow even at concentrations less than 25 μM Hg Cl2 but the transformed cells grow well even at 100 μM HgCl2-(FIG. 10 ). The ability to grow at these high concentrations of mercury in which control is not able to grow, confirms the functionality of both enzymes. Control and transformed clones are grown in LB with 500 μg/rnl of spectinomycin for 24 hours at 37′ C. When OD600 is measured, 1.247 for the clone with 3′ UTR, 0.165 for the clone lacking the 3′ UTR, and zero absorbance for the control is observed. As expected the pLD-merAB-3′UTR transformed clone shows a higher growth rate probably caused by the 3′ effective termination which allows cells to make more copies of the mer operon transcript that contain only the aadA, merA and merB genes. In chloroplast genome we expect a minor effect in the transcription termination efficiency because the terminator of the genes close to the cassette and downstream can serve as a terminator, once it is integrated in the chloroplast genome by homologous recombination. - Bombardment and regeneration of chloroplast transgenic plants: Tobacco (Nicotiana tabacum var. Petit Havana) plants are grown aseptically by germination of seeds on MSO medium (Daniell 1993). Fully expanded, dark green leaves of about two month old plants are bombarded as described by Daniell (1997). The plants are maintained under 500 μg/ml spectinomycin selection in the three phases; first selection (RMOP medium), second round of selection (RMOP medium) and third selection MSO (rooting medium) (
FIG. 10 ). After these selection events, positive transformants are transferred to soil (FIG. 10 ). The plants are tested for integration of the genes in the chloroplast at first round of selection and before transplanting them to soil. The use of PCR with specific primers that land in the chloroplast genome and in the gene cassette allows us to eliminate mutants and show integration of the selectable marker gene and the mer genes (FIG. 11 ). After PCR testing, the plants are grown in soil and the seeds are collected. - Polymerase Chain Reaction: PCR is done using DNA isolated from control and transgenic plants to distinguish a) true chloroplast transfomants from mutants and b) chloroplast transformants from nuclear transformants. Primers for testing the presence of the aadA (a gene that confers spectinomycin resistance) in transgenic plants are landed on the aadA coding sequence and 16S rRNA gene primers 1IP&1M). In order to test chloroplast integration of the mer genes, one primer is landed on the aadA gene while another is landed on the native chloroplast genome (primers 3P&3M). No PCR product is obtained with nuclear transgenic plants using this set of primers. The primer set (5P & 2M) is used to test integration of the entire gene cassette without any internal deletion or looping out during homologous recombination, by landing on the respective recombination sites. This screening is essential to eliminate mutants and nuclear transformants. In order to conduct PCR analyses in transgenic plants, total DNA from unbombarded and transgenic plants are isolated as described by Edwards et al. (1991). Chloroplast transgenic plants containing the mer gene are moved to second round of selection in order to achieve homoplasmy.
- Southern Blot Analysis: Southern blots are done to determine the copy number of the introduced foreign gene per cell as well as to test homoplasmy. There are several thousand copies of the chloroplast genome present in each plant cell. Therefore, when foreign genes are inserted into the chloroplast genome, it is possible that some of the chloroplast genomes have foreign genes integrated while others remain as the wild type (heteroplasmy). Therefore, in order to ensure that only the transformed genome exists in cells of transgenic plants (homoplasmy), the selection process is continued. In order to confirm that the wild type genome does not exist at the end of the selection cycle, total DNA from transgenic plants is probed with the chloroplast border (flanking) sequences (the trnI-trnA fragment). If wild type genomes are present (heteroplasmy), the native fragment size will be observed along with transformed genomes. Presence of a large fragment (due to insertion of foreign genes within the flanking sequences) and absence of the native small fragment should confirm homoplasmy (Daniell et al., 1998; Kota et al., 1999; Guda et al., 2000).
- The copy number of the integrated gene is determined by establishing homoplasmy for the transgenic chloroplast genome. Tobacco Chloroplasts contain 5000-10,000 copies of their genoine per cell (Daniell et al. 1998). If only a fraction of the genomes are actually transformed, the copy number, by default, must be less than 10,000. By establishing that in the transgenics, the merAB inserted transformed genome is the only one present, one could establish that the copy number is 5000-10,000 per cell. This is done by digesting the total DNA with a suitable restriction enzyme and probing with the flanking sequences that enable homologous recombination into the chloroplast genome. The native fragment present in the control should be absent in the transgenics. The absence of native fragment proves that only the transgenic chloroplast genome is present in the cell and there is no native, untransformed, chloroplast genome, without the mer genes present. This establishes the homoplasmic nature of our transformants, simultaneously providing us with an estimate of 5000-10,000 copies of the foreign genes per cell.
- Northern Blot Analysis: Northern blots are done to test the efficiency of transcription of the merAB operon. Total RNA is isolated from 150 mg of frozen leaves by using the “Rneasy Plant Total RNA Isolation Kit” (Qiagen Inc., Chatsworth, Calif.). RNA (10-40 μg) is denatured by formaldehyde treatment, separated on a 1.2% agarose gel in the presence of formaldehyde and transferred to a nitrocellulose membrane (MSI) as described in Sambrook et al. (1989). Probe DNA (merAB gene coding region) is labeled by the random-primed method (Promega) with 32P-dCTP isotope. The blot is pre-hybridized, hybridized and washed as described above for southern blot analysis. Transcript levels are quantified by the Molecular Analyst Program using the GS-700 Imaging Densitometer (Bio-Rad, Hercules, Calif.).
- Germination/Growth Experiments: Seeds of wild-type (Nicotiana tabacum var Petit Havana), transgenic plant pLD-MerAB, and transgenic plant pLD-MerAB-3′UTR are sterilized, vernalized at 4′ C for at least 24 h, and germinated on 1% Phytoagar plates (GIBCO/BRL) made with Murashige and Skoog (4.3 g/liter, GIBCO/BRL) medium containing PMA (phenylmercuric acetate) or mercuric chloride. Seedlings are grown at 22° C. with a 16 h light/8 h dark period.
- Mercury Vapor Assays: Elemental mercury is relatively insoluble and volatile and lost quickly from cells and media. Volatilized Hg0 is measured on a Jerome 431 mercury vapor analyzer (Arizona Instrument, Phoeniz, Ariz.) (Rugh, C. L. et al., 1996). Approximately 5-10 seedlings (10-14 day old, 10-25 mg total wet weight) are incubated in 2 ml of assay medium (50 mm Tris.HCL, pH 6.8/50 mM NaCl/25 uM HgCl2) in a 16×130 mm test tube with a side arm for gas removal. The Hg Cl2 is added to initiate the assay. The amount of Hg0 produced is assayed by bubbling air through the bottom of the sample for 12 sec at 3 cm3/sec and measuring the release of Hg0. The time zero assay will be taken immediately after the seedlings are placed in the medium. The sample is then reassayed every minute for 10 minutes. The volatilized Hg0 is measured by passing the air sample released from the side arm directly over the gold foil membrane resistor of a Jerome 431 mercury vapor analyzer. The instrument is repeatedly standardized with known quantities of Hg0 (10-200 ng), reduced from HgCl2 with excess SnCl2. The amount of mercury evolved is normalized by dividing the number of nanograms of Hg0 measured by the number of milligrams of seedling tissue in the assay.
- Photosynthetic studies: From transgenic plants and untransformed plants, intact chloroplasts are isolated for photosynthetic studies. O2 evolution is studied in an oxygen evolution electrode in the absence or presence of different concentrations of HgCl2 and PMA. Electron transport is studied with suitable electron donors/acceptors to study photosystem I, II or both. PAGE is used to examine the composition of PSII complex, especially EP33, after incubation of cells or chloroplasts or thylakoid membranes with different concentrations of HgCl2 and PMA. In vivo chloroplast fluorescence is studied to monitor changes in control and transformed cells or chloroplasts to measure Fo, Fm, Fv.
- Inheritance of Introduced Foreign Genes: While it is unlikely that introduced DNA would move from the chloroplast genome to nuclear genome, it is possible that the gene could get integrated in the nuclear genome during bombardment and remain undetected in Southern analysis. Therefore, in initial tobacco transformants, some are allowed to self-pollinate, whereas others are used in reciprocal crosses with control tobacco (transgenics as female accepters and pollen donors; testing for maternal inheritance). Harvested seeds (T1) are germinated on media containing spectinomycin. Achievement of homoplasmy and mode of inheritance is classified by looking at germination results. Homoplasmy is indicated by totally green seedlings (Daniell et al., 1998) while heteroplasmy is displayed by variegated leaves (lack of pigmentation, Svab & -Maliga, 1993). Lack of variation in chlorophyll pigmentation among progeny also underscores the absence of position effect, an artifact of nuclear transformation. Maternal inheritance is demonstrated by sole transmission of introduced genes via seed generated on transgenic plants, regardless of pollen source (green seedlings on selective media). When transgenic pollen is used for pollination of control plants, resultant progeny would not contain resistance to chemical in selective media (will appear bleached; Svab and Maliga, 1993). Molecular analyses confirms transmission and expression of introduced genes, and T2 seed are generated from those confirmed plants by the analyses described above.
- Chlorella vulgaris transformation vector: The
region 16S to 23S of the Chlorella vulgaris chloroplast genome is amplified by PCR using specific primers complementary to rrn16 and to rrn23. The PCR product will be cloned into pCR 2.1 vector available from Promega. ThePCR product 16S to 23S is removed from the pCR2.1 vector by a blunt end restriction endonuclease and cloned into the pUC19 in which the multiple cloning site has been removed using a blunt end restriction enzyme (Pvu1I). Then the cassette containing the promoter, the antibiotic resistance gene and the merAB genes is inserted into the new vector (Chlorella transformation vector) using a blunt end restriction enzyme (HincII) that is present in the spacer region between trnA and trnT. The final construct is used for the transformation of Chlorella vulgaris (FIG. 12 ). - Bombardment and transformation of Chlorella vulgaris: The biolistic transformation method (Sanford et al. 1993) is optimized for transformation of Chlorella vulgaris. Chlorella is grown in liquid heterotrophic medium (5 sporulation agar) at 25° C. to late-log phase (˜6×106 cells/ml). To prepare a monolayer for bombardment (2×107), cells are collected onto prewetted 45 mm GVWP filters (Millipore) under gentle (30 mbar) vacuum. Gold particles are coated with the transforming plasmid. (Sanford et al. 1993) The monolayer filters are bombarded. Immediately after bombardment, filters are transferred to selective solid media containing 500 μg/ml spectinomycin and incubated at 22° C. under high light. After approximately 6 weeks, green colonies are picked from a background of bleached cells onto selective plates and grown for an additional 1-2 weeks. Colonies are harvested and screened for integration of foreign genes when they reached a diameter of approximately 5 mm.
- Chlorella vulgaris Bioassays: Growth and colonies formation bioassay are performed as explained in the plant germination growth experiment; the only change is the use of Chlorella specific media.
- Mercury vapor assays: Mercury vapor assays are performed in the way explained for plants above except changing the growth media specific to Chlorella, including temperature and light intensity.
- Photosynthetic studies: Photosynthetic studies are performed in the way explained for plants above except untransformed and transformed Chlorella cells will be directly used to study the effect of mercury toxicity.
- Synechocystis transformation vector: The
region 16S to 23S of the Synechocystis genome is amplified by PCR using specific primers complementary to rrn116 and to rrn23. The PCR product is cloned into the pCR2.1 vector available from Promega. ThePCR product 16S to 23S is removed from the pCR2.1 vector by a blunt end restriction endonuclease and cloned into pUC19 in which the multiple cloning site has been removed using a blunt end restriction enzyme (Pvu1I). Then the cassette containing the promoter, the antibiotic resistance gene and the merAB genes is inserted into the new vector (Synechocystis transformation vector) using a blunt end restriction enzyme (HincII) that is present in the spacer region between trnI and trnA. The final construct will be used for the transformation of Synechocystis (FIG. 13 ). - Transformation of Synechocystis: A fresh culture of wild type in BG-11 (heterotrophic medium) plus glucose is grown to OD730=0.5 after 2-3 days of culture. Cells are spun down in sterile 50 ml tubes at room temperature and resuspended in the original growth medium to OD730=2.5. Transforming DNA is added to resuspended cells in sterile glass culture tubes. Tubes are placed in rack in the growth chamber at 30° C. for 6 hours and shaken for 3 hours. Cells (200 μl) are plated on a sterile filter that has been placed on a BG-11 plus glucose plate and spread around. After growth for 24 hours and they are transferred to filters on appropriate medium containing spectinomycin or mercuric chloride.
- Synechocystis Bioassays: Growth and colonies formation bioassay are performed as explained in the plant germination-growth experiment; the only change is the use Synechocystis growth media.
- Mercury vapor assays: Mercury vapor assays are performed in the way explained for plants above except changing the growth media specific to the Synechocystis, including temperature and light intensity.
- Photosynthetic studies: Photosynthetic studies are performed in the way explained for plants above except untransformed and transformed Synechocystis cells are directly used to study the effect of mercury toxicity.
- Lemna transformation vector: The Lemna chloroplast vector, as shown in
FIG. 14 , is constructed in the same way as explained above for tobacco, with the exception that the Lemna chloroplast DNA flanking sequences are used. - Bombardment and regeneration of transgenic plants: Lemna plants are transformed and regenerated in the way explained for tobacco in Example 1 above.
- Plant Bioassays Various plant bioassays are performed as explained for tobacco in Example 1 above.
- Sugarcane transformation vector: The Sugarcane chloroplast vector, as shown in
FIG. 15 , is constructed in the same way as explained above for tobacco, with the exception that the Sugarcane chloroplast DNA flanking sequences are used. - Bombardment and regeneration of transgenic plants: Sugarcane plants are transformed and regenerated in the way explained for tobacco in Example 1 above.
- Plant Bioassays Various plant bioassays are performed as explained for tobacco in Example 1 above.
-
- Begley T P A, Walts A E, Walsh C T (1986) Mechanistic studies of a protonolytic organornercurial cleaving enzyme: bacterial organomercurial lyase. Biochemistry 25: 7192-7200.
- Bernier M, Popovic R, Carpentier R (1993) Mercury inhibition of
photosystem 11. FEBS Lett. 32: 19-23. - Bernier M, Carpentier R (1995) The action of mercury on the binding of extrinsic polypeptides associated with water oxidizing complex of photosystem. II.
- Bizily S, Rugh C C, Summers A O, Meagher R B (1999) Phytorernediation of methyl mercury pollution: merB expression in Arabidopsis thaliana plants confer resistance to organornercurial. PNAS 96: 6808-6813.
- Bizily S, Rugh C C, Meagher R B (2000) Phytoremediation of hazardous organomercurials by genetically engineered plants. Nature Biotechnology 18; 213-217.
- Bogorad, L. Engineering chloroplasts: an alternative site for foreign genes, proteins, reactions, and products. Trends in Biotechnology. 18, 257-263 (2000).
- Bradley, D. et al. The insecticidal CrylB crystal protein of Bacillus thuringiensis ssp. Thuringiensis has dual specificity to coleopteran and lepidopteran larvae. J. Invert. Pathol. 65, 162-173 (1995).
- Carlson P S (1973) The use of protoplasts for genetic research. Proc. Natl. Acad. Sci. USA 70: 598-602.
- Compeau G C, Bartha R (1985) Sulfate-reducing bacteria: principal methylators in freshwater sediments. Appl. Environ. Microbiol, 50: 498-502.
- Crickmore, N. & Ellar, D. Involvement of a possible chaperonin in the efficient expression of a cloned crylIA 8-enclotoxin gene in Bacillus thuringiensis. MoL Microbiol. 6, 1533-1537 (1992).
- Crickmore, N., Wheeler, V. & Ellar, D. Use of an operon fusion to induce expression and crystallisation of a Bacillus thuringiensis 5-endotoxin encoded by a cryptic gene. MoL Gen. Genet. 242, 365-368 (1994).
- Daniell, H. Foreign gene expression in chloroplasts of higher plants mediated by tungsten particle bombardment. Methods Enzymo/. 217, 536-556 (1993).
- Daniell, H. et al. Engineering plants for stress tolerance via organelle genomes. NATO ASI Series. 86, 589-592 (1994).
- Daniell, H. Transformation and foreign gene expression in plants mediated by microprojectile bombardment. Meth. Mol. Biol. 62, 463-489 (1997).
- 1 A operons on the formation of Cry2A inclusions in Bacillus thuringiensis. FEMS Microbiol. Lett. 165, 35-41 (1998).
- Daniell, H. et al. Containment of a herbicide resistance through genetic engineering of the chloroplast genome. Nature Biotechnol. 16, 345-348 (1998).
- Daniell, H. GM crops: public perception and scientific solutions. Trends in Plant Science. 4, 467-469 (1999).
- Daniell, H. New tools for chloroplast genetic engineering. Nat. Biotechno'll. 17, 855-856 (1999).
- Daniell H, Kulandaivelu G and Chandrasingh U (1980) Substituted p-benzoquinones having high electron affinity as photosystem II electron acceptors. Z. Naturforsch. 35C, 136-138.
- Daniell H and Sarojini G (1981) Site of action of 2,5-dimethoxy-3,6-dichloro-p-benzoqliinone in the photosynthetic electron transport chain. Z. Naturforsch. 36C, 656-661.
- Daniell H, Rarnanujan P, Krishnan M, Gnanam A, Rebeiz C A (1983) In vitro synthesis of photosynthetic membranes: I. Development of photosystem I activity and cyclic phosphorylation. Biochem. Biophys. Res. Comun. 11 1: 740-749.
- Daniell H, Krishnan M, Renganathan M and Gnanam A (1984) Radioisotopic evidence for the polypeptides associated with photosystem II activity. Biochem. Biophys. Res. Commun. 125, 988-995.
- Daniell H, Anbudurai P R, Periyanan S, Renganathan M, Bhardwaj R, Kulandaivelu G and Gnanam A (1985) Oxygenic photoreduction of methyl viologen without the involvement of photosystem I during plastid development. Biochem. Biophys. Res. Commun. 126, 1114-1121.
- Daniell H and McFadden B A (1986) Characterization of DNA uptake by the cyanobacterium Anacystis nidulans. Mol. Gen. Genetics 204, 243-248.
- Daniell H, Sarojini G and McFadden BA (1986) Transformation of the cyanobacterium Anacystis nidulans 6301 with the Escherichia coli plasmid pBR322. Proc. Natl.
Acad. Sci. USA 83, 2546-2550. - Daniell H and McFadden B A (1987) Uptake and expression of bacterial and cyanobacterial genes by isolated cucumber etioplasts. Proc. Natl. Acad. Sci. USA 84: 6349-6353.
- Daniell H and McFadden B A (1988) Genetic Engineering of plant chloroplasts. U.S. Pat. Nos. 5,932,479; 5,693,507.
- Daniell H, Vivekananda J, Neilsen B, Ye G N, Tewari K K, Sanford J C (1990) Transient foreign gene expression in chloroplasts of cultured tobacco cells following biolistic delivery of chloroplast vectors. Proc. Natl. Acad. Sci. USA 87: 88-92.
- Daniell H, Krishnan M, McFadden B A (1991) Expression of B-glucuronidase gene in different cellular compartments following biolistic delivery of foreign DNA into wheat leaves and calli. Plant Cell Reports 9: 615-619.
- Daniell H, Muthukumar B and Lee S B (2001) Marker free transgenic plants: engineering the chloroplast genome without the use of antibiotic selection. Current Genetics. In press.
- DeCosa B, Moar W, Lee S B, Miller M, Daniell H (2001). Hyper-expression of the Bt Cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nature Biotechnol. 19: 71-74.
- De Wilte, C. et. al. (2000). Plants as Bioreacters for Protein Production: Avoiding the Problem of Transgene Silencing. Plant Molecular Biology 43:347-389.
- Edwards K, Johnstone C, Thompson C (1991) A simple and rapid method for preparation of plant genomic DNA for PCR analysis. Nucleic Acids Res. 19: 1349.
- Foster T J (1983) Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol. Rev. 47: 361-409.
- Ge, B. et al. Differential effects of helper proteins encoded by the cry2A and cryl Greenplate, J. Quantification of Bacillus thuringiensis insect control protein CrylAc over time in bollgard cotton fruit and terminals. J. Econ. Entomo/. 92, 1377-1383 (1999).
- Gilmour C C, Henry E A, Mitchel R (1992) Sulfate stimulation of mercury methylation in freshwater sediments. Environ. Sci. Technol. 26: 2281-2287.
- Guda, C., Lee, S. B. & Daniell, H. Stable expression of a biodegradable protein-based polymer in tobacco chloroplasts. Plant Cell Reports. 19, 257-262 (2000).
- Harada M, Minarnata Disease Research Group (1995) Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit. Rev. Toxicol. 25: 1-24.
- Kota, et al. Overexpression of the Bacillus thuringiensis (13t) Cry2Aa?
protein 9 in chloroplasts confers resistance to plants against susceptible and Bt-resistant insects. Proc. Natl. Acad. Sci. 96, 1840-1845 (1999). - Kulandaivelu G and Daniell H. (1980) Dichlorophenyl dimethylurea (DCMU) induced increase in chlorophyll a fluorescence intensity: An index of photosynthetic oxygen evolution in leaves, chloroplasts and algae. Physiol. Plant. 48, 385-388.
- Ma, J. et al. Generation and assembly of secretary antibodies in plants. Science. 268, 716-719 (1995).
- McBride K E, Svab Z, Schaaf D J, Hogen P S, Stalker D M, Maliga P (1995) Amplification of a chimeric Bacillus gene in chloroplasts leads to extraordinary level of an insecticidal protein in tobacco. Bio/technology 13: 362-365.
- Minamata Disiase Research Group (1968) Minamata Disease. (Medical School of Kumamoto University, Kumamoto, Japan)
- Moar, W. et al. Insecticidal activity of the CryllA protein from the NRD-12 isolate of Bacillus thuringiensis subsp. kurstaki expressed in Escherichia coli and Bacillus thuringiensis and in a leaf-colonizing strain of Bacillus cereus. Appl. Environ. Microbiol. 60, 896-902 (1994).
- Moar, W. et al. Development of Bacillus thuringiensis Cryl C resistance by Spodoptera exigua. Appl. Environ. Microbiol. 61, 2086-2092 (1995).
- Navrath, C., Poirier, Y., & Somerville, C. Targeting of the polyhydroxybutyrate biosynthetic pathway to the plastis of Arabidopsis thaliana results in high levels of polymer accumulation. Proc. Natl. Acad. Sci. 91, 12760-12764 (1994).
- Peerenboom, E (2000) German health minister calls time out for Bt maize. Nature Biotechnol. 18: 374.
- Puchta H (2000) Removing selectable marker genes: taking the shortcut. Trends in plant Science 5: 273-274.
- Rashid A, Popovic R (1990) Protective role of CaCl2 against Pb2+ inhibition in photosystem II. FEBS Lett. 271: 181-184.
- Roy, H.&Nierzwicki-Bauer, S. RuBis Co: genes, structure, assembly and evolution. The Photosynthetic Apparatus, L. Bogorad, 1. Vasil (eds), pp 347-364, Academic Press, NY. (1994).
- Rugh C C, Summers A O, Meagher R B (1996) Mercuric ion reductase and resistance in transgenic Arabidopsis thaliana plants expressing modified bacterial merA gene. PNAS 93: 3182-3187.
- Salt D E et al. (1998) Phytoremediation. Rev. Plant. Physiol. Plant. Mol. Biol. 49: 643-668.
- Sanford J C, Smith F D, Russell J A (1993) Optimizing the biolistic process for different biological applications. Methods Enzymol. 217: 483-509.
- Sambrook J. Fritch E F, Maniatis T (1989) Molecular cloning. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
- Sarojini G, Daniell H and Vermaas W F J (1981) Site of electron acceptance by 3,6,dichloro-2,5-dimethoxy-p-benzoquinone and its relation to the bicarbonate effect on photosynthetic electron transport Biochem. Biophys. Res. Commun. 102, 944-951.
- Sidorov V A, Kasten D, Pang S Z, Hajdukiewicz P T J, Staub J M, Nehra N S (1999) Stable chloroplast transformation in potato: use of green fluorescent protein as a plastid marker. Plant Journal 19:209-216.
- Staub J M, Garcia B, Graves J, Hajdukiewicz P T J, Hunter P, Nehra N, Paradkar V, Schlittler M, Caroll J A, Spatola L, Ward D, Ye G, Russell D (2000) High-yield production of human therapeutic protein in tobacco chloroplast. Nature Biotechnol. 18: 333-338.
- Summers A O, Silver S (1978) Microbial transformation of metals. Annu. Rev. Microbiol. 32: 637-672.
- Summers A O (1986) Organization, expression, and evolution of genes for mercury resistance. Annu. Rev. Microbiol. 40: 607-634.
- Svab Z, Maliga P (1993) High frequency plastid transformation in tobacco by selection for a chimeric aadA gene. Proc. Natl. Acad. Sci. USA 90: 913-917.
- Trebs A (1980) Inhibitors in electron flow: tools for the functional and structural localization of carriers and energy conservation sites.
- A. J Vrekleij, J. M. Leunissen (eds.), Immuno-gold Labeling in Cell Biology CRC Press, Boca Raton, Fla. (1989).
- Yamamoto, T. & lizuka, T. Two types of entomocidal toxins in the parasporal crystals of Bacillus thuringiensis var. kurstaki. Archives Biochem. Biophys. 227, 233241 (1983).
- Ye, X. et al, Engineering the provitamin A (0-carotene) biosynthetic pathway into (carotenoid-free) rice enclosperm. Science. 287, 303-305 (2000).
- Herbicide Resistance Crops, Agricultural, Environmental, Economic, Regulatory and Technical Aspects, Duke, S. O., edt., CRC Press, Inc. (1996).
- Herbicide Resistance in Plants, Biology and Biochemistry, Powles, S. B., and Holtum, J. A. M., eds., CRC Press, Inc. (1994).
- Peptides: Design, Synthesis, and Biological Activity, Basava, C. and Anantharamaiah, G. M., eds., Birkhauser Boston, 1994.
- Protein Folding Deciphering the Second Half of the Genetic Code, Gierasch, L. M., and King, J., eds., American Association For the Advancement of Science (1990).
Claims (60)
1. A stable chloroplast transformation and expression vector which is capable of introducing multiple genes into a selected plant by a single integration event, wherein each step of said multiple genes is carried out by an enzyme encoding a heterologous DNA sequence which comprises an expression cassette, comprising as operably linked components, in the 5′ to the 3′ direction of translation, a promoter operative in said plastids which drives a multi-gene operon, a selectable marker sequence, the multi-gene operon which is functional to co-express multiple enzymes in the plastids, a transcription termination region functional in said plastids, and flanking each side of the expression cassette, flanking DNA sequences which are homomlogous to DNA sequences inclusive of a spacer sequence of the target plastid genome, whereby stable integration of the heterologous coding sequence into the chloroplast genome of the target plant is facilitated throughout homologous recombination of the flanking sequence with the homologous sequences in the target plastid gene.
2. A vector of claim 1 , wherein a gene of the operon codes for an insecticidal toxin crystal protein.
3. A vector of claim 2 , wherein the insecticidal toxin crystal protein is a Bacillus thuringiensis (Bt) crystal protein.
4. A vector of claim 3 , wherein another gene of the operon codes for another insecticidal crystal protein with a different mode of action
5. A vector of claim 4 , wherein the multi-gene operon is functional to co-express, in addition to a Bt insecticidal toxin gene, a non-Bt insecticidal toxin gene selected from at least one of the group of cholesterol oxidase, alpha-amylate inhibitors, protease inhibitors, cowpea trypsin inhibitors and the potato proteinase inhibitor II, whereby the “pyramiding” of the toxin product tends to retard the ability of insects to adapt to the insecticidal effect of the transgenic target plants.
6. A vector of claim 4 or 5 , wherein a second gene of the operon codes for a putative chaperonin which facilitates the folding of the Bt crystal toxin protein to form proteotically stable cuboidal crystals.
7. A vector of claim 3 , wherein the operon includes one of the 133 genes shown in the article MMBR, (September, 1998, pages 805-873, Vol 62, No. 4, Revision of the Nomenclature for the Bt Pesticidal (insecticidal) Crystal Proteins by Crickmon, et al.), wherein at least one of the genes of the operon codes for a Bt insecticidal crystal protein and another gene codes for a putative corresponding chaperonin which facilitates the folding and the corresponding chaperonin facilitates the folding of the Bt protein to proteolytically stable cuboidal crystals shown in that MMBR article.
8. A vector of claim 1 , wherein at least one of the gene of the operon codes for a biopharmaceutical protein.
9. A vector of claim 7 , wherein another gene of the operon codes for a putative chaperonin which facilitates the folding of the protein.
10. A vector of claim 8 , wherein the protein is insulin or human albumin.
11. A vector of claim 7 , wherein another gene of the operon codes for another biopharmaceutical protein other than the gene which codes for the putative chaperonin, which protein is expressed in stoichimetric ratio.
12. A vector of claim 10 , wherein the genes of the operon, other than the gene which codes for the putative chaperonin, codes for biopharmaceutical proteins which are expressed in stoichimetric ratio.
13. A vector of claims 7 , 8 , 9 or 10 which comprises collecting the protein product in a folded configuration, thereby enhancing their stability, and facilitating single step purification.
14. A method of combating insects which comprises applying to the insects or their habitat an insecticidally amount of the insecticidal crystal protein of claim 4 .
15. A method of transforming a chloroplast of a selected plant species or the progeny thereof to confer insect resistance and producing on a large-scale foreign protein, said method comprising the steps of:
stably transforming the chloroplast of selected plant cells to express at least one insecticidal toxin protein and a chaperonin, growing the transformed plant cells under conditions which allow the expression of said insecticidal toxin protein and chaperonin.
16. The method of claim 14 , further comprising the steps of culturing said plant cells in a plant growth medium comprising spectinomycin, and selecting transformed plant cells capable of growth in the presence of said spectinomycin.
17. The method of claim 15 , further comprising regenerating a transformed plant from said transformed plant cells.
18. A transformed plant which has been transformed by the method of any one of claims 14 -16.
19. The transformed plant of claim 18 , wherein said plant contains a high accumulation of insecticidal toxin proteins in said plant's leaves, including mature and old bleached leaves.
20. The progeny, including seeds, of the transformed plant of claim 18 .
21. A vector of claim 1 , wherein the biosynthetic pathway is a bioremediation system that functions to degrade inorganic and organic metal compounds in contaminated sites.
22. A vector of claim 21 , wherein the expression cassette does not contain a terminator.
23. A vector of claim 21 or claim 22 , wherein the operon contains the mercury resistance coding sequences encoding enzymes Mer A and Mer B.
24. The vector of claim 23 , wherein the bioremediation pathway is driven by a single promoter.
25. The chloroplast transformation and expression vector of claim 24 , wherein enzymes of the bioremediation pathway are expressed in stoichiometric amounts.
26. A vector of claim 25 , wherein the inorganic compounds are selected from at least one of the group consisting of divalent cations of mercury, nickel, cobalt, trivalent cations of gold, and monovalent cations of silver.
27. A vector of claim 25 , wherein the organic compounds are selected from at least one of the group consisting of alkyl mercury, alkenyl mercury, alkynyl mercury, aromatic mercury compounds, alkyl lead compounds, alkyl arsenic compounds and alkyl cadmium compounds.
28. A method of transforming a chloroplast of a selected plant species or the progeny thereof to confer greater resistance to metal ions than the corresponding parental plant which does not require several back crosses to create complete pathway that detoxifies mercury and organiomercurial, said method comprising the steps of:
stably transforming the chloroplast of a plant by inserting an expression cassette containing the mercury resistance coding sequences of claim 21 into a plant species or the progeny thereof, growing the transforming plant species under conditions which allow the expression of said expression cassette.
29. The method of claim 28 , further comprising culturing said plant in a plant growth medium comprising a selector for the corresponding selectable marker of claim 1 , and selecting transformed plant cells capable of growth in the presence of said selector.
30. The method of claim 29 , further comprising regenerating a transformed plant from said transformed plant cells.
31. A stably transformed plant which has been transformed by the methods of any one of claims 28 -30.
32. The progeny, including seeds, of the stably transformed plant of claim 31 .
33. A method of phytoremediation of mercury and organomercurials in soil and ground water, said method comprising the steps of:
planting the stably transformed plant of either claim 31 or claim 32 in soil contaminated with mercury and organomercurials and allowing said plants to grow.
34. A method of phytoremidation which does not require several back crosses to create complete pathway that detoxifies mercury and organomercurial, said method comprising the methods of claims 28 -30.
35. The plants of claim 33 , wherein the plant contains products of the bioremediation pathway.
36. The products of the stably transformed plant of either claim 31 or claim 32 , wherein said products are metals that are reduced by the enzymes of the bioremediation pathway.
37. The vector of claim 23 which is capable of introducing a multiple-step biosymethtic pathway into a selected photosynthetic cell by a single integration event
38. The vector of claim 37 , wherein the biosynthetic pathway degrades inorganic and organic mercury compounds.
39. A vector of claim 38 , wherein the bioremediation pathway is driven by a single promoter.
40. A vector of claim 38 , wherein the enzymes of the bioremediation pathway are expressed in stoichiometric amounts.
41. A vector of claim 38 , wherein the inorganic compounds are selected from at least one of a group consisting of divalent cations of mercury, nickel, cobalt, trivalent cations of gold, and monovalent cations of silver.
42. A vector of claim 38 , wherein the organic compounds are selected from at least one of a group consisting of alkyl mercury, alkenyl mercury, alkynyl mercury, aromatic mercury compounds, alkyl lead compounds, alkyl arsenic compounds and alkyl cadmium compounds.
43. A photosynthetic organism transformed with the vector of claim 38 which is useful for bioremediation of mercury and organomercurial compounds from contaminated water bodies.
44. A method of transforming a chloroplast of a selected photosynthetic organism to confer greater resistance to metal ions, said method comprising the steps of:
stably transforming the chloroplast of a photosynthetic organism with the vector of claim 38 , growing the transformed photosynthetic organism under conditions which allow the expression of said expression cassette.
45. The method of claim 44 , further comprising culturing said photosynthetic organism in a growth medium comprising a selector, and selecting transformed cells capable of growth in the presence of said selector.
46. The method of claim 45 , further comprising regenerating a transgenic photosynthetic organism from said transformed cells.
47. A method of phytoremediation of mercury and organomercurials in bodies of contaminated water, said method comprising the steps of:
treating water contaminated with mercury and organomercurials with the transgenic photosynthetic organism of claim 42 before releasing the water into the environment.
48. The photosynthetic organism of claim 43 , wherein said photosynthetic organism is either a green algae or a cyanobacteria.
49. The photosynthetic organism of claim 48 , wherein the green algae is Chlorella vulgaris.
50. The photosynthetic organism of claim 48 , wherein the cyanobacteria is Synechocystis.
51. A vector of claim 1 wherein a multi-gene operon codes for a protein.
52. A vector of claim 51 , wherein the protein is a biopharmaceutical protein.
53. A vector of claim 52 , wherein the biopharmaceutical protein is a monoclonal antibody.
54. A vector of claim 53 , wherein the protein is produced in the same stoichiometric ratio.
55. A vector of claim 4 , wherein said another gene of the operon is selected from the group of cholesterol oxidase, alpha-amylase inhibitors, and proteinase inhibitors.
56. The vector of any one of claims 1 -13, 21-27, 37-42, 51-55, wherein the promoter is a one functional in green or non-green plastids.
57. The promoter of claim 56 , wherein said promoter is selected from the group of psbA, accD, or 16srRNA promoters.
58. The biosynthetic pathway of claim 1 , wherein said biosynthetic pathway result in the production of compounds such as amino acids, fatty acids, carbohydrates, polymers, vitamins, antibiotics and dyes.
59. A vector of claim 8 , where the protein is human serum albumin.
60. A vector of claim 1 , which further comprises flanking each side of the expression cassette, flanking DNA sequences which are homologous to a DNA sequence inclusive of a spacer sequence of the target chloroplast genome, which sequence is conserved in the chloroplast genome of different plant species, whereby stable integration of the heterologous coding sequence into the chloroplast genome of the target plant is facilitated through homologous recombination of the flanking sequences with the homologous sequences in the target chloroplast genome.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/938,331 US20080241916A1 (en) | 2001-02-28 | 2007-11-12 | Multiple Gene Expression For Engineering Novel Pathways And Hyperexpression Of Foreign Proteins in Plants |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/006276 WO2001064024A1 (en) | 2000-02-29 | 2001-02-28 | Multiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants |
US09/807,723 US20030041353A1 (en) | 2001-04-18 | 2001-02-28 | Mutiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants |
US10/770,183 US7294506B2 (en) | 2000-02-29 | 2004-02-02 | Tobacco chloroplast transformation vectors comprising a multi-gene operon encoding a biopharmaceutical protein and a chaperonin |
US11/938,331 US20080241916A1 (en) | 2001-02-28 | 2007-11-12 | Multiple Gene Expression For Engineering Novel Pathways And Hyperexpression Of Foreign Proteins in Plants |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/770,183 Continuation US7294506B2 (en) | 2000-02-29 | 2004-02-02 | Tobacco chloroplast transformation vectors comprising a multi-gene operon encoding a biopharmaceutical protein and a chaperonin |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080241916A1 true US20080241916A1 (en) | 2008-10-02 |
Family
ID=25197056
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/807,723 Abandoned US20030041353A1 (en) | 2000-02-29 | 2001-02-28 | Mutiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants |
US10/770,183 Expired - Lifetime US7294506B2 (en) | 2000-02-29 | 2004-02-02 | Tobacco chloroplast transformation vectors comprising a multi-gene operon encoding a biopharmaceutical protein and a chaperonin |
US11/938,331 Abandoned US20080241916A1 (en) | 2001-02-28 | 2007-11-12 | Multiple Gene Expression For Engineering Novel Pathways And Hyperexpression Of Foreign Proteins in Plants |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/807,723 Abandoned US20030041353A1 (en) | 2000-02-29 | 2001-02-28 | Mutiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants |
US10/770,183 Expired - Lifetime US7294506B2 (en) | 2000-02-29 | 2004-02-02 | Tobacco chloroplast transformation vectors comprising a multi-gene operon encoding a biopharmaceutical protein and a chaperonin |
Country Status (1)
Country | Link |
---|---|
US (3) | US20030041353A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9657302B2 (en) | 1998-05-15 | 2017-05-23 | The Trustees Of The University Of Pennsylvania | Expression of human interferon in transgenic chloroplasts |
US9724400B2 (en) | 2009-11-09 | 2017-08-08 | The Trustees Of The University Of Pennsylvania | Administration of plant expressed oral tolerance agents |
US10689633B2 (en) | 2008-02-29 | 2020-06-23 | The Trustees Of The University Of Pennsylvania | Expression of β-mannanase in chloroplasts and its utilization in lignocellulosic woody biomass hydrolysis |
US10752909B2 (en) | 2007-03-30 | 2020-08-25 | The Trustees Of The University Of Pennsylvania | Chloroplasts engineered to express pharmaceutical proteins in edible plants |
US10865419B2 (en) | 2011-10-24 | 2020-12-15 | The Trustees Of The University Of Pennsylvania | Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes |
WO2022026341A1 (en) * | 2020-07-28 | 2022-02-03 | The Regents Of The University Of California | Expressing multiple genes from a single transcript in algae and plants |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7227057B2 (en) | 1997-06-03 | 2007-06-05 | Chromatin, Inc. | Plant centromere compositions |
US7235716B2 (en) | 1997-06-03 | 2007-06-26 | Chromatin, Inc. | Plant centromere compositions |
US7119250B2 (en) | 1997-06-03 | 2006-10-10 | The University Of Chicago | Plant centromere compositions |
US7193128B2 (en) | 1997-06-03 | 2007-03-20 | Chromatin, Inc. | Methods for generating or increasing revenues from crops |
US6639050B1 (en) | 1997-07-21 | 2003-10-28 | Ohio University | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
US7378506B2 (en) * | 1997-07-21 | 2008-05-27 | Ohio University | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
US6548642B1 (en) * | 1997-07-21 | 2003-04-15 | Ohio University | Synthetic genes for plant gums |
US6570062B1 (en) * | 1997-07-21 | 2003-05-27 | Ohio University | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
US7741536B2 (en) * | 1997-08-07 | 2010-06-22 | University Of Central Florida Research Foundation, Inc. | Expression of human serum albumin in plastids |
US7989202B1 (en) | 1999-03-18 | 2011-08-02 | The University Of Chicago | Plant centromere compositions |
AU2003251764A1 (en) * | 2002-07-03 | 2004-01-23 | University Of Central Florida | Phytoremediation of contaminant compounds via chloroplast genetic engineering |
US20040142476A1 (en) * | 2002-11-01 | 2004-07-22 | New England Biolabs, Inc. | Organellar targeting of RNA and its use in the interruption of environmental gene flow |
US7256327B2 (en) * | 2002-11-29 | 2007-08-14 | The University Of Hong Kong | Genetically modified plants expressing proteinase inhibitors, SaPIN2a or SaPIN2b, and methods of use thereof for the inhibition of trypsin- and chymotrypsin-like activities |
US20060252120A1 (en) * | 2003-05-09 | 2006-11-09 | Kieliszewski Marcia J | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
CA2530994A1 (en) * | 2003-07-01 | 2005-01-20 | Biolex, Inc. | Chloroplast transformation of duckweed |
NZ548513A (en) * | 2004-01-14 | 2010-05-28 | Univ Ohio | Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
US8729341B2 (en) * | 2004-02-23 | 2014-05-20 | University Of Chicago | Plants modified with mini-chromosomes |
EP1751177A4 (en) * | 2004-04-19 | 2008-07-16 | Univ Ohio | Cross-linkable glycoproteins and methods of making the same |
WO2006108830A2 (en) * | 2005-04-13 | 2006-10-19 | Bayer Cropscience Sa | TRANSPLASTOMIC PLANTS EXPRESSING α 1-ANTITRYPSIN |
US20080242834A1 (en) * | 2005-07-08 | 2008-10-02 | Ohio University | Methods of Predicting Hyp-Glycosylation Sites For Proteins Expressed and Secreted in Plant Cells, and Related Methods and Products |
EP1929019A2 (en) | 2005-09-08 | 2008-06-11 | Chromatin, Inc. | Plants modified with mini-chromosomes |
WO2008112972A2 (en) * | 2007-03-15 | 2008-09-18 | Chromatin, Inc. | Centromere sequences and minichromosomes |
US20080256669A1 (en) * | 2007-04-16 | 2008-10-16 | Monsanto Company | Plants with Multiple Transgenes on a Chromosome |
GB2449466B (en) * | 2007-05-23 | 2009-11-18 | Algentech Ltd | Production of proteins in plant tissue |
KR20130020842A (en) | 2007-06-01 | 2013-02-28 | 더 스크립스 리서치 인스티튜트 | High throughput screening of genetically modified photosynthetic organisms |
WO2009017821A1 (en) * | 2007-08-01 | 2009-02-05 | Bioglow Inc. | Bioluminescent plants comprising bacterial lux operon and methods of making same |
MX2010002723A (en) * | 2007-09-11 | 2010-05-21 | Sapphire Energy Inc | Molecule production by photosynthetic organisms. |
AR069893A1 (en) * | 2007-12-19 | 2010-02-24 | Basf Plant Science Gmbh | PLANTS WITH HIGHER PERFORMANCE AND / OR HIGHER TOLERANCE TO THE ENVIRONMENTAL STRESS (IY-BM) |
BRPI0922735A2 (en) | 2008-12-10 | 2017-06-13 | Synthetic Genomics Inc | production of branched chain alcohols through photosynthetic microorganisms. |
EP2448955B1 (en) | 2009-06-29 | 2015-09-30 | Synthetic Genomics, Inc. | Acyl-acp thioesterase genes and uses therefor |
CA2767724A1 (en) | 2009-07-23 | 2011-01-27 | Chromatin, Inc. | Sorghum centromere sequences and minichromosomes |
US8633002B2 (en) | 2009-08-11 | 2014-01-21 | Synthetic Genomics, Inc. | Microbial production of fatty alcohols |
ES2665516T3 (en) | 2010-12-23 | 2018-04-26 | Exxonmobil Research And Engineering Company | Genetically modified microorganisms comprising 4-hydroxybenzoyl-CoA-thioesterase, and methods of using them to produce free fatty acids, fatty acid derivatives and 4-hydroxybenzoyl-CoA-thioesterase |
WO2012087673A1 (en) | 2010-12-23 | 2012-06-28 | Exxonmobil Research And Engineering Company | Prokaryotic acyl-acp thioesterases for producing fatty acids in genetically engineered microorganisms |
US9175256B2 (en) | 2010-12-23 | 2015-11-03 | Exxonmobil Research And Engineering Company | Production of fatty acids and fatty acid derivatives by recombinant microorganisms expressing polypeptides having lipolytic activity |
WO2012092033A1 (en) | 2010-12-31 | 2012-07-05 | Exxonmobil Research And Engineering Company | Enhancement of biomass production by disruption of light energy dissipation pathways |
US9096834B2 (en) | 2012-02-24 | 2015-08-04 | Exxonmobil Research And Engineering Company | Recombinant microorganisms comprising thioesterase and lysophosphatidic acid acyltransferase genes for fatty acid production |
US9181568B2 (en) | 2012-04-23 | 2015-11-10 | Exxonmobil Research And Engineering Company | Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases |
EP2909304A4 (en) | 2012-10-16 | 2016-09-21 | Exxonmobil Res & Eng Co | Dgat genes and methods of use for triglyceride production in recombinant microorganisms |
US8835149B2 (en) | 2012-12-06 | 2014-09-16 | Exxonmobil Research And Engineering Company | DGAT genes comprising pleckstrin homology domains and methods of use for triglyceride production in recombinant microorganisms |
ES2682279T3 (en) | 2012-12-06 | 2018-09-19 | Synthetic Genomics, Inc. | Algae mutants that have an intense light acclimatized phenotype in compartments |
CN103114102B (en) * | 2013-01-29 | 2014-12-03 | 华南农业大学 | Polygene vector assembly method and application |
EP3430123A1 (en) | 2016-03-18 | 2019-01-23 | ExxonMobil Research and Engineering Company | Chlorophyllase overproduction to enhance photosynthetic efficiency |
FR3135094A1 (en) * | 2022-05-02 | 2023-11-03 | Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement | Bacterial heterologous protein expression system |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5576198A (en) * | 1993-12-14 | 1996-11-19 | Calgene, Inc. | Controlled expression of transgenic constructs in plant plastids |
US5693507A (en) * | 1988-09-26 | 1997-12-02 | Auburn University | Genetic engineering of plant chloroplasts |
US5965796A (en) * | 1995-04-21 | 1999-10-12 | University Of Georgia Research Foundation Inc. | Metal resistance sequences and transgenic plants |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250515A (en) | 1988-04-11 | 1993-10-05 | Monsanto Company | Method for improving the efficacy of insect toxins |
US5932479A (en) | 1988-09-26 | 1999-08-03 | Auburn University | Genetic engineering of plant chloroplasts |
US5436392A (en) | 1990-01-12 | 1995-07-25 | Arizona Technology Development Corporation | Transgenic plants expressing M. sexta protease inhibitor |
US5877402A (en) * | 1990-05-01 | 1999-03-02 | Rutgers, The State University Of New Jersey | DNA constructs and methods for stably transforming plastids of multicellular plants and expressing recombinant proteins therein |
AU2422792A (en) | 1991-07-30 | 1993-03-02 | Bio-Technical Resources | Device for detecting aqueous contaminants |
US5763245A (en) | 1991-09-23 | 1998-06-09 | Monsanto Company | Method of controlling insects |
US5661017A (en) | 1993-09-14 | 1997-08-26 | Dunahay; Terri Goodman | Method to transform algae, materials therefor, and products produced thereby |
US5491076A (en) | 1993-11-01 | 1996-02-13 | The Texas A&M University System | Expression of foreign genes using a replicating polyprotein producing virus vector |
US5545817A (en) | 1994-03-11 | 1996-08-13 | Calgene, Inc. | Enhanced expression in a plant plastid |
US5545818A (en) | 1994-03-11 | 1996-08-13 | Calgene Inc. | Expression of Bacillus thuringiensis cry proteins in plant plastids |
US5869719A (en) | 1995-03-08 | 1999-02-09 | Novartis Finance Corporation | Transgenic plants having increased biotin content |
US6004782A (en) | 1995-04-14 | 1999-12-21 | Bioelastics Research Ltd. | Hyperexpression of bioelastic polypeptides |
US5958745A (en) | 1996-03-13 | 1999-09-28 | Monsanto Company | Methods of optimizing substrate pools and biosynthesis of poly-β-hydroxybutyrate-co-poly-β-hydroxyvalerate in bacteria and plants |
US6140486A (en) | 1997-06-04 | 2000-10-31 | Calgene Llc | Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants |
WO1999005265A2 (en) * | 1997-07-23 | 1999-02-04 | Sanford Scientific, Inc. | Improved plastid transformation of higher plants and production of transgenic plants with herbicide resistance |
BR9815611B1 (en) * | 1997-08-07 | 2013-09-17 | expression and universal integration vector competent to stably transform the chloroplast genome of different plant species and process to stably transform a target upper plant species | |
AR020090A1 (en) | 1998-06-15 | 2002-04-10 | John Innes Ct | MONOCOTILEDONE VEGETABLE CELL OR SEED OF HER, PLANT OR PART OF A PLANT, METHOD FOR MAKING A MONOCOTILEDONE VEGETABLE CELL, METHOD FOR MAKING AN APPLIANCE, USE OF AN EXPRESSION CONSTRUCTION TO PRODUCE A PLANT CELL AND SED OF CONSTRUCTION EXPRESSION |
BR9912019A (en) | 1998-07-10 | 2002-02-19 | Calgene Llc | Expression of eukaryotic peptides in plant plastids |
WO2001007590A2 (en) | 1999-07-27 | 2001-02-01 | Syngenta Participations Ag | Chimeric genes for plastid expression |
-
2001
- 2001-02-28 US US09/807,723 patent/US20030041353A1/en not_active Abandoned
-
2004
- 2004-02-02 US US10/770,183 patent/US7294506B2/en not_active Expired - Lifetime
-
2007
- 2007-11-12 US US11/938,331 patent/US20080241916A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5693507A (en) * | 1988-09-26 | 1997-12-02 | Auburn University | Genetic engineering of plant chloroplasts |
US5576198A (en) * | 1993-12-14 | 1996-11-19 | Calgene, Inc. | Controlled expression of transgenic constructs in plant plastids |
US5965796A (en) * | 1995-04-21 | 1999-10-12 | University Of Georgia Research Foundation Inc. | Metal resistance sequences and transgenic plants |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9657302B2 (en) | 1998-05-15 | 2017-05-23 | The Trustees Of The University Of Pennsylvania | Expression of human interferon in transgenic chloroplasts |
US10752909B2 (en) | 2007-03-30 | 2020-08-25 | The Trustees Of The University Of Pennsylvania | Chloroplasts engineered to express pharmaceutical proteins in edible plants |
US10689633B2 (en) | 2008-02-29 | 2020-06-23 | The Trustees Of The University Of Pennsylvania | Expression of β-mannanase in chloroplasts and its utilization in lignocellulosic woody biomass hydrolysis |
US9724400B2 (en) | 2009-11-09 | 2017-08-08 | The Trustees Of The University Of Pennsylvania | Administration of plant expressed oral tolerance agents |
US10865419B2 (en) | 2011-10-24 | 2020-12-15 | The Trustees Of The University Of Pennsylvania | Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes |
WO2022026341A1 (en) * | 2020-07-28 | 2022-02-03 | The Regents Of The University Of California | Expressing multiple genes from a single transcript in algae and plants |
Also Published As
Publication number | Publication date |
---|---|
US7294506B2 (en) | 2007-11-13 |
US20040210966A1 (en) | 2004-10-21 |
US20030041353A1 (en) | 2003-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7294506B2 (en) | Tobacco chloroplast transformation vectors comprising a multi-gene operon encoding a biopharmaceutical protein and a chaperonin | |
EP1698699B1 (en) | Improved expression of CRY3B insecticidal protein in plants | |
AU2007228981B2 (en) | Novel genes encoding insecticidal proteins | |
AU2011289286B2 (en) | Methods and compositions for targeting sequences of interest to the chloroplast | |
AU2009200171B2 (en) | Plastid genetic engineering via somatic embryogenesis | |
Liu et al. | Expression of a Bacillus thuringiensis toxin (cry1Ab) gene in cabbage (Brassica oleracea L. var. capitata L.) chloroplasts confers high insecticidal efficacy against Plutella xylostella | |
EP2512222A1 (en) | COMBINED USE OF CRY1Ca AND CRY1Fa PROTEINS FOR INSECT RESISTANCE MANAGEMENT | |
JP2005500849A (en) | Modified Cry3A toxin and nucleic acid sequence encoding the toxin | |
Daniell et al. | Chloroplast genetic engineering | |
EP1263281B1 (en) | Multiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants | |
EP3119187B2 (en) | Cry1d for controlling corn earworm | |
Devine et al. | Chloroplast genetic engineering for enhanced agronomic traits and expression of proteins for medical/industrial applications | |
WO2001011029A1 (en) | Transgenic plants expressing photorhabdus toxin | |
US20060095982A1 (en) | Phytoremediation of contaminant compounds via chloroplast genetic engineering | |
Daniell et al. | Tobacco chloroplast transformation vectors comprising a multi-gene operon encoding a biopharmaceutical protein and a chaperonin (US) | |
AU2012258422B2 (en) | Novel genes encoding insecticidal proteins | |
Daniell | Engineering the chloroplast genome to confer stress tolerance and production of pharmaceutical proteins | |
DUFOURMANTEL | CHLOROPLAST GENETIC ENGINEERING | |
DANIELL et al. | CHLOROPLAST GENETIC ENGINEERING HENRY DANIELL1*, PAUL R. COHILL1, SHASHI KUMAR1, AND NATHALIE DUFOURMANTEL 2 1Department of Molecular Biology and Microbiology, University of Central Florida, Biomolecular ScienceBldg# 20, Room 336, 4000 Central Florida Blvd., Orlando, FL 32816-2364* daniell@ mail. ucf. edu. | |
CA2924415A1 (en) | Novel genes encoding insecticidal proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |